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Carbon-carbon double bond (C=C) formation is a crucial transformation in organic chemistry. Visible-
light photoredox catalysis provides economical and sustainable opportunities for the development of
novel and peculiar organic reactions. Here we report a method for the olefination of alkyl halides with
aldehydes by visible-light photoredox catalysis using triphenylphosphine as a reductive quencher
(103 examples). This transformation accommodates a variety of aldehydes including paraformalde-
hyde; aqueous formaldehyde; 2,2,2-trifluoroacetaldehyde monohydrate; 2,2,2-trifluoro-1-methoxye-
thanol; and other common aldehydes. The present method exhibits several advantages, including
operational simplicity, mild reaction conditions, wide functional group tolerance, and amenability
to gram-scale synthesis.We anticipate that it will be widely used in the synthesis of organic molecules,
natural products, biological molecules, and polymers.
INTRODUCTION
The formation of carbon-carbon double bonds is a key chemical transformation in organic chemistry (Liu
et al., 2004; Nicolaou and Sorensen, 1996; Nicolaou and Snyder, 2003; Saklani and Kutty, 2008). Besides
direct elimination (Clayden et al., 2001), four routine and reliable methods for the synthesis of alkenes are
widely used: the Wittig reaction (Wittig and Geissler, 1953; Wittig and Schollkopf, 1954), the Peterson re-
action (Peterson, 1968), the Julia-Lythgoe (Julia and Paris, 1973; Kocienski et al., 1978)/Julia-Kocienski
(Baudin et al., 1991; Blakemore et al., 1998) olefination reactions, and alkene metathesis reactions (Cal-
deron et al., 1967; Garber et al., 2000; Love et al., 2002; Murdzek and Schrock, 1987; Nicolaou et al.,
2005; Scholl et al., 1999; Schrock, 1999; Schwab et al., 1996). In 1953, Georg Wittig discovered that treat-
ing an aldehyde or ketone with a phosphonium ylide gave an alkene (Wittig and Geissler, 1953; Wittig
and Schollkopf, 1954). Since then, the Wittig reaction has been extensively used in organic synthesis (Ko-
lodiazhnyi, 1999; Maryanoff and Reitz, 1989; Nicolaou et al., 1997). However, the classical Wittig reaction
usually required heating conditions and long reaction times. Recently, photoredox catalysis has become a
powerful strategy for the activation of molecules, and some unprecedented reactions have been devel-
oped, thanks to the ability of photoredox catalysts to cleanly transform visible light into prominent levels
of chemical energy (Hari and Ko¨nig, 2013; Ravelli et al., 2009; Jin and Fu, 2017; Ko¨nig, 2013; Narayanam
and Stephenson, 2011; Shaw et al., 2016; Shi and Xia, 2012; Xuan and Xiao, 2012; Yoon et al., 2010; Zeitler,
2009). For the past year, we have indeed developed some valuable visible-light photoredox organic re-
actions (Gao et al., 2016; Jiang et al., 2016a, 2016b, 2016c, 2017; Jin et al., 2016a, 2016b, 2016c, 2017; Li
et al., 2016). Inspired by the robustness and excellent achievements of photoredox catalysis, we hypoth-
esized that a straightforward procedure might be developed to enable C=C bond formation via coupling
of alkyl halides with aldehydes and their derivatives using triphenylphosphine as a reductive quencher. In
developing a method for direct coupling of alkyl halides with aldehydes, we hoped to introduce a
new paradigm for C=C bond construction that would (1) provide rapid access to terminal and internal
alkenes and 3,3,3-trifluoropropenyl derivatives and (2) enable C=C bond formation in aqueous solvent
mixtures.
A proposed mechanism for the coupling of alkyl halides with aldehydes is described in Figure 1. Initial
visible-light excitation of the photocatalyst [Ru(bpy)3]Cl2 (A) or [Ir(ppy)2](dtbbpy)PF6 (C) (dtbbpy = 4,4
0-
di-tert-butyl-2,20-bipyridine) would yield excited-state *Ru(II) (IA) or *Ir(III) (IC) complex. The complex
(IA or IC) is a strong single-electron oxidant (half-wave redox potential E1/2
red [*RuII/RuI] = +0.77 V [Prier
et al., 2013]; E1/2
red [*IrIII/IrII] = + 0.66 V versus the saturated calomel electrode [SCE] in CH3CN [Lowry
et al., 2005]) and should undergo reduction by triphenylphosphine (E1/2
red = 0.87 V versus SCE in MeCN102 iScience 6, 102–113, August 31, 2018 ª 2018 The Author(s).
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Figure 1. Proposed Mechanism for the Cross-Coupling of Alkyl Halides with Aldehydes[Yasui et al., 2000]) to give Ru(I) (IIA) or Ir(II) (IIC) complex and radical cation Ph3P
,+ (III) (Fearnley et al., 2016).
A single electron transfer from Ru(I) (IIA) or Ir(II) (IIC) to alkyl halide (1) is endergonic but might be possible
under the assistance of III via formation of a charge-transfer complex. This should provide alkyl radical IV
and halo anion (X) and regenerate photocatalystA orC. The resulting alkyl radical IV is expected to rapidly
react with aldehyde 2 to produce oxygen-centered radical V (Kawamoto et al., 2012). This intermediate is
prone to b-scission, but combination of V with Ph3P
,+ (III) to give oxyphosphonium ion VI would drive the
reaction forward. Finally, elimination of VI in the presence of base forges the desired C=C bond to furnish
the coupled product (3, 4, or 5).RESULTS AND DISCUSSION
Optimization Study
Generally, terminal alkenes are prepared via Wittig coupling of aldehydes with methyltriphenylphospho-
nium halide in the presence of strong bases such as potassium tert-butoxide. We realized that it should
be more simple, economical, and practical if they were synthesized through coupling of alkyl halides
with paraformaldehyde or aqueous formaldehyde in the presence of common inorganic bases and triphe-
nylphosphine (PPh3), so we subsequently started optimization of conditions on the visible-light photoredox
olefination of alkyl halides (1) with paraformaldehyde (2a). As shown in Table 1, 4-bromobenzyl bromide
(1a) was selected as the reaction partner to optimize conditions, including photocatalysts, bases, solvents,
amount of triphenylphosphine, and reaction time. Four common ruthenium and iridium complexes,
[Ru(bpy)3]Cl2,6H2O (A), [fac-Ir(ppy)3] (B), [Ir(ppy)2](dtbbpy)PF6 (C), and [Ir(dFCF3ppy)2](dtbbpy)PF6 (D),
were screened as photocatalysts (entries 1–4) using Cs2CO3 as the base and acetonitrile as the solvent
in the presence of 1.5 equiv of PPh3 under argon atmosphere at room temperature for 6 hr, and
[Ru(bpy)3]Cl2,6H2O (A) exhibited the highest catalytic activity, providing 1-bromo-4-vinylbenzene (3i) in
93% yield with triphenylphosphine oxide as a by-product appearing in 95% yield (entry 1). Meanwhile, [Ir(p-
py)2](dtbbpy)PF6 (C) afforded 3i in 87% yield (entry 3). Other bases, K2CO3 (entry 5) and Na2CO3 (entry 6),
were screened, and K2CO3 afforded the same yield as Cs2CO3 (compare entries 1 and 5) but Na2CO3 gave a
slightly lower yield (entry 6). Only small amounts of target product were observed in the absence of base
(entry 7). The stoichiometry of PPh3 was changed, and we found that 1.5 equiv of PPh3 was optimal
(compare entries 5, 8, and 9). The reaction did not work in the absence of PPh3 (entry 10). We investigated
reaction time (entries 11 and 12) and found that the reaction completed within 4 hr. Other solvents were
tested (entries 13–16), and they were inferior to MeCN. Reactions in polar protic solvents such as ethanol,
isopropanol, and tert-butanol did not deliver the product. Aqueous formaldehyde (2b) (37% aqueous
solution) could be used instead of paraformaldehyde (2a) to give the product (3i) in a reasonable yield
(84%) (entry 17). The reaction was carried out under irradiation of a 5-W blue light-emitting diode
for 9 hr, and a yield similar to the one in entry 11 was obtained (entry 18), which indicated that the
UV part of the compact fluorescent light (CFL) emission spectrum was not mandatory and that the reaction
proceeded indeed under visible-light irradiation. The presence of air inhibited the reaction (entry 19).
Only trace amounts of target product were observed in the absence of photocatalyst (entry 20) or
visible light (entry 21). Therefore, the optimized conditions for synthesis of terminal alkenes are asiScience 6, 102–113, August 31, 2018 103
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Entry PC Base (equiv) Solvent Time (h) Yielda
1 A Cs2CO3 CH3CN 6 93
2 B Cs2CO3 CH3CN 6 21
3 C Cs2CO3 CH3CN 6 89
4 D Cs2CO3 CH3CN 6 67
5 A K2CO3 CH3CN 6 93
6 A NA2CO3 CH3CN 6 61
7b A – CH3CN 6 11
8c A K2CO3 CH3CN 6 92
9d A K2CO3 CH3CN 6 80
10e A K2CO3 CH3CN 6 NR
11 A K2CO3 CH3CN 4 93
12 A K2CO3 CH3CN 3 88
13 A K2CO3 DMF 4 90
14 A K2CO3 DMA 4 74
15 A K2CO3 DMSO 4 43
Table 1. Optimization of Conditions for Visible-Light Photoredox Olefination
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Entry PC Base (equiv) Solvent Time (h) Yielda
16 A K2CO3 CH2Cl2 4 45
17f A K2CO3 CH3CN 4 84
18g A K2CO3 CH3CN 9 90
19h A K2CO3 CH3CN 4 Trace
20i – K2CO3 CH3CN 4 Trace
21j A K2CO3 CH3CN 4 Trace
Table 1. Continued
Reaction conditions: Ar atmosphere and irradiation of visible light with 23-W CFL, 4-bromobenzyl bromide (1a) (1.0 mmol),
paraformaldehyde (2a) (2.0 mmol, relative to amount of formaldehyde), triphenylphosphine (PPh3) (1.5 mmol), photocatalyst
(5.0 mmol), base (1.5 mmol), solvent (10 mL), temperature (room temperature 25 oC), time 3–6 hr, in a sealed Schlenk tube.
PC, photocatalyst; CFL, compact fluorescent light; DMA, N,N-dimethylacetamide; NR, no reaction.
aIsolated yield.
bNo base.
cIn the presence of 2 equiv of PPh3.
dIn the presence of 1 equiv of PPh3.
eNo PPh3.
fUsing aqueous formaldehyde (2b) (37% aqueous solution) (2.0 mmol) instead of paraformaldehyde (2a).
gUnder irradiation of 5-W blue LED light for 9 hr.
hThe reaction was carried out in air.
iNo photocatalyst.
jNo light.
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Figure 2. Visible-Light Photoredox Synthesis of Terminal Alkenes
(A) Synthesis of terminal alkenes with paraformaldehyde (2a).
(B) Synthesis of terminal alkenes with hydrous formaldehyde (2b).
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Figure 2. Continued
(C) Gram-scale synthesis of 3i.
Reaction conditions: Ar atmosphere and irradiation of visible light with 23-W CFL, [Ru(bpy)3]Cl2,6H2O (A) or [Ir(ppy)2]
dtbbpyPF6 (C) (5.0 mmol), alkyl bromide (1) (1.0 mmol), paraformaldehyde (2a) (4.0 mmol for the synthesis of 3n–3p;
2.0 mmol for the synthesis of the others, relative to the amount of formaldehyde), aqueous formaldehyde (2b)
(37% aqueous solution) (2.0 mmol), triphenylphosphine (PPh3) (3.0 mmol for synthesis of 3n–3p; 1.5 mmol for synthesis of
the others), K2CO3 (3.0 mmol for synthesis of 3n–3p; 1.5 mmol for synthesis of the others), MeCN (10 mL),
temperature (room temperature [rt], 25C), time, 4–12 hr, in a sealed Schlenk tube. Isolated yield. E/Z ratios were
determined by 1H nuclear magnetic resonance spectroscopy. See Transparent Methods for experimental details.follows: [Ru(bpy)3]Cl2,6H2O (A) as the photocatalyst, K2CO3 as the base, and 1.5 equiv of PPh3 in MeCN as
the solvent under argon atmosphere at room temperature.Scope of the Investigation
With optimal conditions in hand, we probed the generality of this process with respect to alkyl halides (1)
(Figure 2A). At first, various substituted benzyl bromides or chlorides were tested using A as the photoca-
talyst, and they provided the corresponding terminal alkenes in good to excellent yields (see 3a–3m), with
bromides exhibiting higher reactivity than chlorides. When 1,2-dibenzyl bromide; 1,3-dibenzyl bromide;
and 1,4-dibenzyl bromide were used as the substrates, 1,2-divinylbenzene; 1,3-divinylbenzene; and 1,4-di-
vinylbenzene were prepared in satisfactory yields (see 3n–3p). Benzyl bromide derivatives containing am-
ides, such as substrates derived from amino acids, also performed very well under the standard conditions
(see 3q–3t). (E)-(3-bromoprop-1-en-1-yl)benzene and bromoacetamide derivatives (Nakajimaet al., 2014)
were used in visible-light olefination using [Ir(ppy)2]dtbbpyPF6 (C) as the photocatalyst and afforded the
corresponding terminal alkenes uneventfully (see 3u–3aa). Subsequently, olefination of substituted benzyl
bromides with aqueous formaldehyde (2b) was investigated. As shown in Figure 2B, the reactions also
provided the corresponding terminal alkenes in good yields. We performed a gram-scale experiment
using 1a as an example under the standard conditions, and 3.3 g of 1-bromo-4-vinylbenzene (3i) was ob-
tained in 90% yield (Figure 2C). This result shows that this visible-light-mediated method is effective and
practical for the synthesis of styrene and acrylamide derivatives. Unfortunately, other kinds of unactivated
alkyl halides were not successful substrates under the present conditions, and further investigations are
underway. The method tolerates various functional groups including ethers; aryl C-F and C-Br bonds;
trifluoromethyl, cyano, and nitro groups; and N-heterocycles, amides, and esters, and no epimerization
was observed on using amino acid-derived substrates. Notably, the olefination of alkyl halides is carried
out in a one-pot system, which avoids the separate preparation of the Wittig reagents. In addition, the
method displays several advantages including mild conditions; use of inexpensive and readily available
paraformaldehyde, aqueous formaldehyde, and common inorganic bases; as well as easy operation and
workup procedures.
It is well known that the CF3 group is ubiquitous in pharmaceuticals, agrochemicals, and functional mate-
rials, resulting in elevated electronegativity, hydrophobicity, metabolic stability, and bioavailability (Banks
et al., 1994; Filler and Kobayashi, 1982; Jeschke, 2004; Mueller et al., 2007; Purser et al., 2008; Shimizu and
Hiyama, 2005; Welch and Eswarakrishman, 1991) compared with their non-fluorinated counterparts, so it is
highly desirable to develop efficient and practical methods for introducing the trifluoromethyl group into
organic molecules (Liang et al., 2013; Ma and Cahard, 2007; Schlosser, 2006; Tomashenko and Grushin,
2011). Inspired by the excellent results mentioned above, we explored the coupling of benzyl halides
with 2,2,2-trifluoroacetaldehyde hydrate (2c) (75% aqueous solution) or 2,2,2-trifluoro-1-methoxyethanol
(2d) (Figure 3). Reaction of substituted benzyl bromides with 2c or 2d led to substituted 3,3,3-trifluoropro-
penes under similar conditions to those in Figure 2A, and treatment of bromoacetamides with 2c
provided 4,4,4-trifluorobut-2-enamides, which after in situ Michael addition of water afforded 4,4,4-tri-
fluoro-3-hydroxybutanamides (4l–4o). This visible-light-mediated method introducing the trifluoromethyl
group afforded good to excellent yields with tolerance of several functional groups, although no E/Z selec-
tivity was observed for the synthesis of 3,3,3-trifluoropropenes.
Next, various common aldehydes (2) were tested using substituted benzyl bromides (1) as partners (Fig-
ure 4). All benzaldehyde derivatives exhibited high reactivity, and the presence of neutral, electron-
donating, and electron-withdrawing groups on the aromatic rings did not obviously affect the yields
(see 5a–5t). a,b-Unsaturated aldehydes (see 5u and 5v) and aliphatic aldehydes (see 5w–5ae) also provediScience 6, 102–113, August 31, 2018 107
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Figure 3. Synthesis of 3,3,3-Trifluoropropenes and 4,4,4-Trifluoro-3-hydroxybutanamides
Reaction conditions: Ar atmosphere and irradiation of visible light with 23-W CFL; Ru(bpy)3Cl2,6H2O (A) or
Ir(ppy)2dtbbpyPF6 (C) (5.0 mmol); alkyl bromide (1) (1.0 mmol); 2,2,2-trifluoroacetaldehyde hydrate (2c) (75% aqueous
solution) (2.2 mmol for synthesis of 4j and 4k; 1.1 mmol for others); 2,2,2-trifluoro-1-methoxyethanol (2d) (1.1 mmol);
triphenylphosphine (PPh3) (3.0 mmol for synthesis of 4j and 4k; 1.5 mmol for synthesis of the others); K2CO3 (3.0 mmol for
synthesis of 4j and 4k; 1.5 mmol for synthesis of the others); MeCN (10 mL); temperature (room temperature [rt], 25C);
time, 6–12 hr; in a sealed Schlenk tube. Isolated yield. E/Z ratios were determined by 1H nuclear magnetic resonance
spectroscopy. See Transparent Methods for experimental details.to be good substrates. We attempted the coupling of benzyl bromide with ethyl glyoxylate, and the target
product (5af) was obtained in 71% yield. Interestingly, the reactions of bromomethyl arenes with aromatic
aldehydes only provided trans-alkenes, whereas mixtures of cis- and trans-alkenes were obtained for the
other substrates. Reaction of glutaraldehyde (2e) with 2 equiv of benzyl bromide (1b) gave diene 5ag in
87% yield. Interestingly, coupling of 1,2-bis(bromomethyl)benzene (1c) with o-phthalaldehyde (2f) pro-
vided dibenzo[a,e]cyclooctene 5ah in 62% yield. The results showed that the present method is nearly uni-
versal with respect to the aldehyde scope.
We then explored the substrate scope of alkyl halides using benzaldehyde derivatives as partners. As
shown in Figure 5, various bromomethyl arenes exhibited high reactivity, and the electronic effects on
the aromatic rings did not cause noticeable differences in reactivity (see 5ai–5au). Bromoacetonitrile, allyl
bromide, and 3-bromo-2-methylpropene were also suitable substrates (see 5av–5bb). Bromoacetic acid
derivatives with ester (see 5bc) and amides (see 5bd–5bg) were attempted as substrates and displayed
high reactivity. Similarly, benzyl bromide derivatives derived from amino acids also gave the target prod-
ucts in high yields (see 5bh–5bk). A one-to-one late-stage fragment coupling between dipeptide 1d and
amino acid derivative 2g was attempted, and excitingly, conjugate 5bl was obtained in 91% yield. In108 iScience 6, 102–113, August 31, 2018
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Figure 4. Variation of Aldehydes on Visible-Light Photoredox Olefination
Reaction conditions: Ar atmosphere and irradiation of visible light with 23-W CFL, Ru(bpy)3Cl2,6H2O (A) (5.0 mmol) or Ir(ppy)2dtbbpyPF6 (C) (10 mmol), alkyl
bromide (1) (1.5 mmol), aldehyde (2) (1.0 mmol), triphenylphosphine (PPh3) (1.5 mmol), K2CO3 (1.5 mmol), DMF (2.0 mL), temperature (room temperature [rt]
25C), time 2–9 hr, in a sealed Schlenk tube. Isolated yield. E/Z ratios were determined by 1H nuclear magnetic resonance spectroscopy. See Transparent
Methods for experimental details.
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Figure 5. Variation of Alkyl Halides on Visible-Light Photoredox Olefination
Reaction conditions: Ar atmosphere and irradiation of visible light with 23-W CFL, Ru(bpy)3Cl2,6H2O (A) (5.0 mmol) or Ir(ppy)2dtbbpyPF6 (C) (10 mmol), alkyl
bromide (1) (1.5 mmol), aldehyde (2) (1.0 mmol), triphenylphosphine (PPh3) (1.5 mmol), K2CO3 (1.5 mmol), DMF (2.0 mL), temperature (room temperature [rt]
25C), time 3–12 hr, in a sealed Schlenk tube. Isolated yield. E/Z ratios were determined by 1H nulcear magnetic resonance spectroscopy. See Transparent
Methods for experimental details.addition, a gram-scale experiment was performed using coupling of benzyl bromide (1b) with 4-chloroben-
zaldehyde (2h) as an example; 1-chloro-4-(2-phenylvinyl)benzene (5i) (19.5 g) was obtained in 91% yield un-
der irradiation of two 23-W CFL bulbs. The results indicate that the present method is effective for diverse
alkyl halides and might be applicable to peptide stapling and bioconjugation reactions.
It should be pointed out that there are limitations and possible disadvantages to the present method,
including use of excess amount of triphenylphosphine and additional photoredox catalysts.
Mechanistic Study
To explore the mechanism for the visible-light photoredox olefination, we carried out some control exper-
iments as follows. (1) Treatment of 4-methylbenzyl bromide (1e) with PPh3 in the absence of aldehyde and
base provided (4-methylbenzyl)triphenylphosphonium bromide (6) in 94% yield (Figure 6A), but only less
amounts of product were observed in the dark. (2) Treatment of (4-methylbenzyl)triphenylphosphonium
bromide (6) with 2i under the standard conditions with or without addition of an extra equivalent of
PPh3 only provided trace amounts of 5ai (Figure 6B), which implies that triphenylphosphonium bromides
are not intermediates in the visible-light photoredox olefination. The result shows that the Wittig reagents
are not reduced by a reductive quenching cycle involving PPh3, even though their reduction potentials
seem more accessible than the ones of benzyl bromides (Matschiner and Issleib, 1967). It also shows
that the base does not deprotonate the ylide to do a classical Wittig reaction. (3) Reaction of 1a with
18O-labeling benzaldehyde (2j) under the standard conditions provided 5b and 18O-labeled triphenylphos-
phine oxide (7) in 90% and 91% yields, respectively (Figure 6C). The result shows that oxygen in triphenyl-
phosphine oxide originates from the aldehyde. We also investigated types of radicals produced during the
reactions by electron spin resonance (see Supplemental Information). The results above indicate that the
process for the visible-light photoredox olefination in Figure 1 is reasonable (see Supplemental Information
for more mechanistic studies). This report is the first example of broadly applicable reduction of simple
benzyl halides by visible-light photoredox catalysis, and more detailed mechanistic studies are underway
to better understand this key step in the catalytic cycle.1e
Br
+
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Me
6
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with or without PPh3 (1.0 equiv), 23 W CFLMe Me
trace amount
+
Br-
PPh3
6 (94% yield)
PPh3
Me
+
Br-
1e
Br
+ 5b (90% yield)H
O18
2j
PPh3 (1.2 equiv), Ru(bpy)3Cl2. 6H2O (0.5 mol%)
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C
Figure 6. Investigation of Mechanism for the Visible-Light Photoredox Olefination
(A) Treatment of 4-methylbenzyl bromide (1e) (0.3 mmol) with triphenylphosphine (1.0 mmol) in the absence of aldehyde
and base under the standard conditions.
(B) Treatment of (4-methylbenzyl)triphenylphosphonium bromide (6) (0.3 mmol) with 2i (0.2 mmol) in the presence or
absence of pph3 (0.3 mmol) under the standard conditions.
(C) Treatment of 4-methylbenzyl bromide (1e) (1.5 mmol) with 18O-labeled aldehyde (2j) (1.0 mmol) under the standard
conditions.
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Conclusion
We have developed an efficient and practical olefination of alkyl halides with aldehydes by visible-light
photoredox catalysis using triphenylphosphine as a reductive quencher. The present method exhibits
several advantages including operational simplicity, mild reaction conditions, wide functional group toler-
ance, and amenability to gram-scale synthesis. More importantly, paraformaldehyde; aqueous formalde-
hyde; 2,2,2-trifluoroacetaldehyde hydrate; and 2,2,2-trifluoro-1-methoxyethanol are also effective sub-
strates, and the corresponding terminal alkenes and CF3-containing molecules were prepared in good
to excellent yields. We believe that the present method will find wide application in the synthesis of organic
molecules, natural products, biological molecules, and polymers.
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Transparent Methods and 240 figures and can be found with this article
online at https://doi.org/10.1016/j.isci.2018.07.011.
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Figure S3. 1H NMR spectrum of 3b, related to Figure 2. 
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Figure S5. 1H NMR spectrum of 3c, related to Figure 2. 
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Figure S7. 1H NMR spectrum of 3d, related to Figure 2. 
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Figure S9. 1H NMR spectrum of 3e, related to Figure 2. 
 
Figure S10. 13C NMR spectrum of 3e, related to Figure 2. 
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Figure S11. 19F NMR spectrum of 3e, related to Figure 2. 
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Figure S12. 1H NMR spectrum of 3f, related to Figure 2. 
 
Figure S13. 13C NMR spectrum of 3f, related to Figure 2. 
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Figure S14. 19F NMR spectrum of 3e, related to Figure 2. 
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Figure S15. 1H NMR spectrum of 3g, related to Figure 2. 
 
Figure S16. 13C NMR spectrum of 3g, related to Figure 2. 
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Figure S17. 1H NMR spectrum of 3h, related to Figure 2. 
 
Figure S18. 13C NMR spectrum of 3h, related to Figure 2. 
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Figure S19. 1H NMR spectrum of 3i, related to Figure 2. 
 
Figure S20. 13C NMR spectrum of 3i, related to Figure 2. 
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Figure S21. 1H NMR spectrum of 3j, related to Figure 2. 
 
Figure S22. 13C NMR spectrum of 3j, related to Figure 2. 
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Figure S23. 19F NMR spectrum of 3j, related to Figure 2. 
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Figure S24. 1H NMR spectrum of 3k, related to Figure 2. 
 
Figure S25. 13C NMR spectrum of 3k, related to Figure 2. 
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Figure S26. 1H NMR spectrum of 3l, related to Figure 2. 
 
Figure S27. 13C NMR spectrum of 3l, related to Figure 2. 
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Figure S28. 1H NMR spectrum of 3m, related to Figure 2. 
 
Figure S29. 13C NMR spectrum of 3m, related to Figure 2. 
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Figure S30. 1H NMR spectrum of 3n, related to Figure 2. 
 
Figure S31. 13C NMR spectrum of 3n, related to Figure 2. 
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Figure S32. 1H NMR spectrum of 3o, related to Figure 2. 
 
Figure S33. 13C NMR spectrum of 3o, related to Figure 2. 
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Figure S34. 1H NMR spectrum of 3p, related to Figure 2. 
 
Figure S35. 13C NMR spectrum of 3p, related to Figure 2. 
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Figure S36. 1H NMR spectrum of 3q, related to Figure 2. 
 
Figure S37. 13C NMR spectrum of 3q, related to Figure 2. 
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Figure S38. 1H NMR spectrum of 3r, related to Figure 2. 
 
Figure S39. 13C NMR spectrum of 3r, related to Figure 2. 
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Figure S40. 1H NMR spectrum of 3s, related to Figure 2. 
 
Figure S41. 13C NMR spectrum of 3s, related to Figure 2. 
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Figure S42. 1H NMR spectrum of 3t, related to Figure 2. 
 
Figure S43. 13C NMR spectrum of 3t, related to Figure 2. 
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Figure S44. 1H NMR spectrum of 3u, related to Figure 2. 
 
Figure S45. 13C NMR spectrum of 3u, related to Figure 2. 
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Figure S46. 1H NMR spectrum of 3v, related to Figure 2. 
 
Figure S47. 13C NMR spectrum of 3v, related to Figure 2. 
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Figure S48. 1H NMR spectrum of 3w, related to Figure 2. 
 
Figure S49. 13C NMR spectrum of 3w, related to Figure 2. 
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Figure S50. 1H NMR spectrum of 3x, related to Figure 2. 
 
Figure S51. 13C NMR spectrum of 3x, related to Figure 2. 
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Figure S52. 1H NMR spectrum of 3y, related to Figure 2. 
 
Figure S53. 13C NMR spectrum of 3y, related to Figure 2. 
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Figure S54. 1H NMR spectrum of 3z, related to Figure 2. 
 
Figure S55. 13C NMR spectrum of 3z, related to Figure 2. 
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Figure S56. 1H NMR spectrum of 3aa, related to Figure 2. 
 
Figure S57. 13C NMR spectrum of 3aa, related to Figure 2. 
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Figure S58. 1H NMR spectrum of 3ab, related to Figure 2. 
 
Figure S59. 13C NMR spectrum of 3ab, related to Figure 2. 
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Figure S60. 1H NMR spectrum of 3ac, related to Figure 2. 
 
Figure S61. 13C NMR spectrum of 3ac, related to Figure 2. 
 
-S34 - 
 
 
Figure S62. 1H NMR spectrum of 4a, related to Figure 3. 
 
Figure S63. 13C NMR spectrum of 4a, related to Figure 3. 
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Figure S64. 19F NMR spectrum of 4a, related to Figure 3. 
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Figure S65. 1H NMR spectrum of 4b, related to Figure 3. 
 
Figure S66. 13C NMR spectrum of 4b, related to Figure 3. 
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Figure S67. 19F NMR spectrum of 4b, related to Figure 3. 
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Figure S68. 1H NMR spectrum of 4c, related to Figure 3. 
 
Figure S69. 13C NMR spectrum of 4c, related to Figure 3. 
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Figure S67. 19F NMR spectrum of 4c, related to Figure 3. 
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Figure S71. 1H NMR spectrum of 4d, related to Figure 3. 
 
Figure S72. 13C NMR spectrum of 4d, related to Figure 3. 
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Figure S73. 19F NMR spectrum of 4d, related to Figure 3. 
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Figure S74. 1H NMR spectrum of 4e, related to Figure 3. 
 
Figure S75. 13C NMR spectrum of 4e, related to Figure 3. 
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Figure S76. 19F NMR spectrum of 4e, related to Figure 3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4e
CF3
Br
-S44 - 
 
 
Figure S77. 1H NMR spectrum of 4f, related to Figure 3. 
 
Figure S78. 13C NMR spectrum of 4f, related to Figure 3. 
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Figure S79. 19F NMR spectrum of 4f, related to Figure 3. 
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Figure S80. 1H NMR spectrum of 4g, related to Figure 3. 
 
Figure S81. 13C NMR spectrum of 4g, related to Figure 3. 
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Figure S82. 19F NMR spectrum of 4g, related to Figure 3. 
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Figure S83. 1H NMR spectrum of 4h, related to Figure 3. 
 
Figure S84. 13C NMR spectrum of 4h, related to Figure 3. 
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Figure S85. 19F NMR spectrum of 4h, related to Figure 3. 
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Figure S86. 1H NMR spectrum of 4i, related to Figure 3. 
 
Figure S87. 13C NMR spectrum of 4i, related to Figure 3. 
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Figure S88. 19F NMR spectrum of 4i, related to Figure 3. 
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Figure S89. 1H NMR spectrum of 4j, related to Figure 3. 
 
Figure S90. 13C NMR spectrum of 4j, related to Figure 3. 
 
4j
CF3F3C
4j
CF3F3C
-S53 - 
 
Figure S91. 19F NMR spectrum of 4j, related to Figure 3. 
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Figure S92. 1H NMR spectrum of 4k, related to Figure 3. 
 
Figure S93. 13C NMR spectrum of 4k, related to Figure 3. 
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Figure S94. 19F NMR spectrum of 4k, related to Figure 3. 
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Figure S95. 1H NMR spectrum of 4l, related to Figure 3. 
 
Figure S96. 13C NMR spectrum of 4l, related to Figure 3. 
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Figure S97. 19F NMR spectrum of 4l, related to Figure 3. 
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Figure S98. 1H NMR spectrum of 4m, related to Figure 3. 
 
Figure S99. 13C NMR spectrum of 4m, related to Figure 3. 
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Figure S100. 19F NMR spectrum of 4m, related to Figure 3. 
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Figure S101. 1H NMR spectrum of 4n, related to Figure 3. 
 
Figure S102. 13C NMR spectrum of 4n, related to Figure 3. 
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Figure S103. 19F NMR spectrum of 4n, related to Figure 3. 
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Figure S104. 1H NMR spectrum of 4o, related to Figure 3. 
 
Figure S105. 13C NMR spectrum of 4o, related to Figure 3. 
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Figure S106. 19F NMR spectrum of 4o, related to Figure 3. 
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Figure S107. 1H NMR spectrum of 5a, related to Figure 4. 
 
Figure S108. 13C NMR spectrum of 5a, related to Figure 4. 
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Figure S109. 1H NMR spectrum of 5b, related to Figure 4. 
 
Figure S110. 13C NMR spectrum of 5b, related to Figure 4. 
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Figure S111. 1H NMR spectrum of 5c, related to Figure 4. 
 
Figure S112. 13C NMR spectrum of 5c, related to Figure 4. 
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Figure S113. 1H NMR spectrum of 5d, related to Figure 4. 
 
Figure S114. 13C NMR spectrum of 5d, related to Figure 4. 
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Figure S115. 1H NMR spectrum of 5e, related to Figure 4. 
 
Figure S116. 13C NMR spectrum of 5e, related to Figure 4. 
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Figure S117. 1H NMR spectrum of 5f, related to Figure 4. 
 
Figure S118. 13C NMR spectrum of 5f, related to Figure 4. 
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Figure S119. 1H NMR spectrum of 5g, related to Figure 4. 
 
Figure S120. 13C NMR spectrum of 5g, related to Figure 4. 
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Figure S121. 1H NMR spectrum of 5h, related to Figure 4. 
 
Figure S122. 13C NMR spectrum of 5h, related to Figure 4. 
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Figure S123. 1H NMR spectrum of 5i, related to Figure 4. 
 
Figure S124. 13C NMR spectrum of 5i, related to Figure 4. 
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Figure S125. 1H NMR spectrum of 5j, related to Figure 4. 
 
Figure S126. 13C NMR spectrum of 5j, related to Figure 4. 
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Figure S127. 1H NMR spectrum of 5k, related to Figure 4. 
 
Figure S128. 13C NMR spectrum of 5k, related to Figure 4. 
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Figure S129. 1H NMR spectrum of 5l, related to Figure 4. 
 
Figure S130. 13C NMR spectrum of 5l, related to Figure 4. 
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Figure S131. 1H NMR spectrum of 5m, related to Figure 4. 
 
Figure S132. 13C NMR spectrum of 5m, related to Figure 4. 
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Figure S133. 19C NMR spectrum of 5m, related to Figure 4. 
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Figure S134. 1H NMR spectrum of 5n, related to Figure 4. 
 
Figure S135. 13C NMR spectrum of 5n, related to Figure 4. 
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Figure S136. 19C NMR spectrum of 5n, related to Figure 4. 
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Figure S137. 1H NMR spectrum of 5o, related to Figure 4. 
 
Figure S138. 13C NMR spectrum of 5o, related to Figure 4. 
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Figure S139. 1H NMR spectrum of 5p, related to Figure 4. 
 
Figure S140. 13C NMR spectrum of 5p, related to Figure 4. 
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Figure S141. 1H NMR spectrum of 5q, related to Figure 4. 
 
Figure S142. 13C NMR spectrum of 5q, related to Figure 4. 
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Figure S143. 1H NMR spectrum of 5r, related to Figure 4. 
 
Figure S144. 13C NMR spectrum of 5r, related to Figure 4. 
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Figure S145. 1H NMR spectrum of 5s, related to Figure 4. 
 
Figure S146. 13C NMR spectrum of 5s, related to Figure 4. 
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Figure S147. 1H NMR spectrum of 5t, related to Figure 4. 
 
Figure S148. 13C NMR spectrum of 5t, related to Figure 4. 
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Figure S149. 11B NMR spectrum of 5t, related to Figure 4. 
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Figure S150. 1H NMR spectrum of 5u, related to Figure 4. 
 
Figure S151. 13C NMR spectrum of 5u, related to Figure 4. 
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Figure S152. 1H NMR spectrum of 5v, related to Figure 4. 
 
Figure S153. 13C NMR spectrum of 5v, related to Figure 4. 
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Figure S154. 1H NMR spectrum of 5w, related to Figure 4. 
 
Figure S155. 13C NMR spectrum of 5w, related to Figure 4. 
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Figure S156. 1H NMR spectrum of 5x, related to Figure 4. 
 
Figure S157. 13C NMR spectrum of 5x, related to Figure 4. 
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Figure S158. 1H NMR spectrum of 5y, related to Figure 4. 
 
Figure S159. 13C NMR spectrum of 5y, related to Figure 4. 
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Figure S160. 1H NMR spectrum of 5z, related to Figure 4. 
 
Figure S161. 13C NMR spectrum of 5z, related to Figure 4. 
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Figure S162. 1H NMR spectrum of 5aa, related to Figure 4. 
 
Figure S163. 13C NMR spectrum of 5aa, related to Figure 4. 
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Figure S164. 1H NMR spectrum of 5ab, related to Figure 4. 
 
Figure S165. 13C NMR spectrum of 5ab, related to Figure 4. 
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Figure S166. 1H NMR spectrum of 5ac, related to Figure 4. 
 
Figure S167. 13C NMR spectrum of 5ac, related to Figure 4. 
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Figure S168. 1H NMR spectrum of 5ad, related to Figure 4. 
 
Figure S169. 13C NMR spectrum of 5ad, related to Figure 4. 
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Figure S170. 1H NMR spectrum of 5ae, related to Figure 4. 
 
Figure S171. 13C NMR spectrum of 5ae, related to Figure 4. 
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Figure S172. 1H NMR spectrum of 5af, related to Figure 4. 
 
Figure S173. 13C NMR spectrum of 5af, related to Figure 4. 
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Figure S174. 1H NMR spectrum of 5ag, related to Figure 4. 
 
Figure S175. 13C NMR spectrum of 5ag, related to Figure 4. 
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Figure S176. 1H NMR spectrum of 5ah, related to Figure 4. 
 
Figure S177. 13C NMR spectrum of 5ah, related to Figure 4. 
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Figure S178. 1H NMR spectrum of 5ai, related to Figure 5. 
 
Figure S179. 13C NMR spectrum of 5ai, related to Figure 5. 
 
Me 5ai
Me
Me 5ai
Me
-S102 - 
 
 
Figure S180. 1H NMR spectrum of 5aj, related to Figure 5. 
 
Figure S181. 13C NMR spectrum of 5aj, related to Figure 5. 
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Figure S182. 1H NMR spectrum of 5ak, related to Figure 5. 
 
Figure S183. 13C NMR spectrum of 5ak, related to Figure 5. 
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Figure S184. 1H NMR spectrum of 5al, related to Figure 5. 
 
Figure S185. 13C NMR spectrum of 5al, related to Figure 5. 
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Figure S186. 19F NMR spectrum of 5al, related to Figure 5. 
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Figure S187. 1H NMR spectrum of 5am, related to Figure 5. 
 
Figure S188. 13C NMR spectrum of 5am, related to Figure 5. 
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Figure S189. 19F NMR spectrum of 5am, related to Figure 5. 
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Figure S190. 1H NMR spectrum of 5an, related to Figure 5. 
 
Figure S191. 13C NMR spectrum of 5an, related to Figure 5. 
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Figure S192. 1H NMR spectrum of 5ao, related to Figure 5. 
 
Figure S193. 13C NMR spectrum of 5ao, related to Figure 5. 
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Figure S194. 1H NMR spectrum of 5ap, related to Figure 5. 
 
Figure S195. 13C NMR spectrum of 5ap, related to Figure 5. 
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Figure S196. 1H NMR spectrum of 5aq, related to Figure 5. 
 
Figure S197. 13C NMR spectrum of 5aq, related to Figure 5. 
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Figure S198. 19F NMR spectrum of 5aq, related to Figure 5. 
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Figure S199. 1H NMR spectrum of 5ar, related to Figure 5. 
 
Figure S200. 13C NMR spectrum of 5ar, related to Figure 5. 
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Figure S201. 1H NMR spectrum of 5as, related to Figure 5. 
 
Figure S202. 13C NMR spectrum of 5as, related to Figure 5. 
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Figure S203. 1H NMR spectrum of 5at, related to Figure 5. 
 
Figure S204. 13C NMR spectrum of 5at, related to Figure 5. 
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Figure S205. 1H NMR spectrum of 5au, related to Figure 5. 
 
Figure S206. 13C NMR spectrum of 5au, related to Figure 5. 
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Figure S207. 1H NMR spectrum of 5av, related to Figure 5. 
 
Figure S208. 13C NMR spectrum of 5av, related to Figure 5. 
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Figure S209. 1H NMR spectrum of 5aw, related to Figure 5. 
 
Figure S210. 13C NMR spectrum of 5aw, related to Figure 5. 
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Figure S211. 1H NMR spectrum of 5ax, related to Figure 5. 
 
Figure S212. 13C NMR spectrum of 5ax, related to Figure 5. 
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Figure S213. 1H NMR spectrum of 5ay, related to Figure 5. 
 
Figure S214. 13C NMR spectrum of 5ay, related to Figure 5. 
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Figure S215. 1H NMR spectrum of 5az, related to Figure 5. 
 
Figure S216. 13C NMR spectrum of 5az, related to Figure 5. 
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Figure S217. 1H NMR spectrum of 5ba, related to Figure 5. 
 
Figure S218. 13C NMR spectrum of 5ba, related to Figure 5. 
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Figure S219. 1H NMR spectrum of 5bb, related to Figure 5. 
 
Figure S220. 13C NMR spectrum of 5bb, related to Figure 5. 
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Figure S221. 1H NMR spectrum of 5bc, related to Figure 5. 
 
Figure S222. 13C NMR spectrum of 5bc, related to Figure 5. 
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Figure S223. 1H NMR spectrum of 5bd, related to Figure 5. 
 
Figure S224. 13C NMR spectrum of 5bd, related to Figure 5. 
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Figure S225. 1H NMR spectrum of 5be, related to Figure 5. 
 
Figure S226. 13C NMR spectrum of 5be, related to Figure 5. 
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Figure S227. 1H NMR spectrum of 5bf, related to Figure 5. 
 
Figure S228. 13C NMR spectrum of 5bf, related to Figure 5. 
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Figure S229. 1H NMR spectrum of 5bf, related to Figure 5. 
 
Figure S230. 13C NMR spectrum of 5bg, related to Figure 5. 
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Transparent Methods 
1. General procedures 
All reactions were carried out in dry solvents under argon atmosphere. Reagents were purchased 
and used without further purification. Reactions were monitored by thin layer chromatography 
(TLC), and the products were obtained by column chromatography on silica gel or preparative thin 
layer chromatography (pTLC). High resolution mass spectra (HRMS) were recorded on a 
Shimadzu LCMS-IT/TOF quadrupole-time of flight mass spectrometer. Electron-impact mass 
spectra were recorded on a JEOL JMS-Q1050GC Master Quad GC/MS. NMR spectra were 
recorded on JOEL JNM-ECA 600, JNM-ECS 400 and JNM-ECA 300 for proton and carbon 
magnetic resonance spectra (1H NMR and 13C NMR). 1H NMR chemical shifts were referenced to 
the hydrogen signal of tetramethylsilane (TMS) (δ = 0.00 ppm) or the residual hydrogen signal of 
deuterated chloroform (δ = 7.26 ppm). In 13C measurements the signal of CDCl3 (δ = 77.0) was 
used as a reference. The following abbreviations were used to explain the multiplicities: s = singlet, 
d = doublet, t = triplet, q = quartet, m = multiplet, b = broad.  
 
2. Synthesis of photocatalysts and substrates 1f, 1g and 2g 
(1) Synthesis of photocatalysts 
Ru(bpy)3Cl2·6H2O was purchased from commercial Energy-Chemical Co. and was used without 
further treatment. 
Synthesis of [fac-Ir(ppy)3]: [fac-Ir(ppy)3] was synthesized according to the previous report 
(Tamayo et al., 2003; Sprouse et al., 1984). Iridium trichloride hydrate (0.388 g) and 
2-phenylpyridine (0.76 g) were dissolved in a mixed solvent of 2-ethoxyethanol (30 mL) and 
water (10 mL), and the solution was refluxed for 24 h. The resulting solution was cooled to room 
temperature to form yellow precipitate, and the yellow precipitate was collected on a glass filter 
frit and was washed with 95% ethanol (60 mL) and acetone (60 mL). The solid was dissolved in 
dichloromethane (75 mL), and the solution was filtered. Toluene (25 mL) and hexane (10 mL) 
were added to the filtrate, which was then reduced in volume by evaporation to 50 mL, and cooled 
to give [Ir(ppy)2Cl]2 [tetrakis(2-phenylpyridine-C2,N')(μ-dichloro)-diiridium] as crystals (0.428 g, 
72%). 
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A mixture of [Ir(ppy)2Cl]2, 2-phenylpyridine (2.5 equiv, 0.155 g) and K2CO3 (10 equiv, 0.544 g) 
was heated to ~200 ℃ under inert atmosphere in 20 mL of glycerol for 20-24 h. After the mixture 
was cooled to room temperature, 20 mL of deionized H2O was added, and the resulting precipitate 
was filtered off, washed with two portions of methanol, followed by ether and hexane. The crude 
product was then flash chromatographed on a silica column using dichloromethane as the eluent to 
provide pure [fac-Ir(ppy)3] (0.17 g, 65%). 
Synthesis of [Ir(ppy)2dtbbpy]PF6: [Ir(ppy)2dtbbpy]PF6 was prepared according to the previous 
report (Slinker et al., 2004). A mixture of [Ir(ppy)2Cl]2 (214 mg, 0.2 mmol) and 
4,4'-di-tert-butyl-2,2'-dipyridyl (118 mg, 0.44 mmol) in 10 mL of 1,2-ethanediol under nitrogen 
atmosphere was heated at 150℃ for 15 h. The solid was dissolved to yield a clear, yellow solution. 
After cooling the resulting solution to room temperature, 150 mL of water was added. Excess of 
bipyridine was removed through extraction with diethyl ether (3×50 mL), and the aqueous layer 
was subsequently heated to 60-70 ℃. NH4PF6 (1.0 g) in 10 mL of water was added, and the PF6 
salt of the chromophore immediately precipitated. After cooling the suspension to 5 ℃, the 
yellow solid was separated through filtration, dried, and recrystallized through acetonitrile/ether 
diffusion. Yield: 273 mg (75%). 
(2) Synthesis of peptides 1f, 1g and 2g 
(A) Synthesis of 1f 
 
To a 50 mL rounded bottom bottle (S)-methyl 2-amino-3-methylbutanoate hydrochloride (1.252 g, 
7.5 mmol), (S)-2-(tert-butoxycarbonylamino)-3-phenylpropanoic acid (1.325 g, 5 mmol) and 
HATU (2.852 g, 7.5 mmol) were added, followed with dry CH2Cl2 (25 mL), the mixture was 
cooled to 0 ℃, then diisopropylethylamine (2.68 mL, 15 mmol) was added, the mixture was 
allowed to warm to room temperature and stirred for 5 h. After dilution with CH2Cl2 (25 mL), the 
mixture was washed with 1N HCl (2 × 50 mL), saturated NaHCO3 (2 × 50 mL). The combined 
aqueous layer was extracted with CH2Cl2 (2 × 40 mL). The organic layers were combined and 
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washed with brine (50mL), dried over Na2SO4, filtered and concentrated. The residue was purified 
by column chromatography to afford product P1 (1.882 g, 92%). To a 50 mL rounded bottom 
bottle with P1 (1.64 g, 4 mmol) in CH2Cl2 (30 mL), CF3COOH (0.75 mL, 10 mmol) was added, 
the reaction was monitored by TLC. After the reaction completed, the solvent was removed under 
reduced pressure, and the crude product was used without further purification. 2,6-Lutidine (1.4 
mL, 12 mmol) was added to the crude product above in CH2Cl2 (20 mL). After the mixture was 
cooled to 0 oC, a fresh synthesized 4-(bromomethyl)benzoyl chloride (5 mmol) in CH2Cl2 (10 mL) 
was added dropwise to the mixture, then the solution was warmed to room temperature and stirred 
for 4 h. After the reaction completed, the solution was poured into 50 mL of 1 N HCl, another 20 
mL of CH2Cl2 was added to the mixture, then washed with 1N HCl (2 × 50 mL), the combined 
aqueous layer was extracted with CH2Cl2 (2 × 20 mL). The combined organic layer was washed 
with brine, dried with Na2SO4, filtered and evaporated under reduced pressure, and the residue 
was purified by silica gel column chromatography to afford desired product (S)-methyl 
2-((S)-2-(4-(bromomethyl)benzamido)-3-phenylpropanamido)-3-methylbutanoate (1f), 1.28 g 
(67% yield). 1H NMR (CDCl3, 400 MHz) 7.72 (d, J = 8.25 Hz, 2H), 7.38 (d, J = 8.25 Hz, 2H), 
7.23-7.20 (m, 6H), 6.92 (d, J = 8.59 Hz, 1H), 5.03 (q, J = 7.22 Hz, 1H), 4.57 (s, 2H), 4.46-4.44 (m, 
1H), 3.69 (s, 3H), 3.21-3.14 (m, 2H), 2.13-2.05 (m, 1H), 0.83 (q, J = 8.22 Hz, 6H). 13C NMR 
(CDCl3, 100 MHz) 171.8, 171.4, 166.8, 141.1, 136.7, 133.7, 129.5, 128.74, 128.67, 127.7, 127.0, 
57.6, 55.0, 52.2, 45.5, 38.3, 31.1, 19.0, 17.9. ESI-MS: (M+H)+ m/z 475 
(S)-Methyl 2-((S)-2-(4-(bromomethyl)benzamido)propanamido)-3-phenylpropanoate (1g) was 
synthesized through the same procedures described above. Yield: 69%. 1H NMR (CDCl3, 400 
MHz) 7.75 (d, J = 8.25 Hz, 2H), 7.43 (d, J = 8.25 Hz, 3H), 7.16-7.13 (m, 3H), 7.06 (d, J = 7.56 Hz, 
2H), 6.98 (d, J = 7.56 Hz, 1H), 6.90 (d, J = 7.90 Hz, 1H), 4.86 (q, J = 7.22 Hz, 1H), 4.77-4.72 (m, 
1H), 4.60 (s, 2H), 3.73 (s, 3H), 3.16-3.03 (m, 2H), 1.44 (d, J = 8.59 Hz, 3H). 13C NMR (CDCl3, 
100 MHz) 172.1, 171.8, 166.5, 141.2, 135.7, 133.7, 129.3, 128.8, 128.7, 127.7, 127.2, 53.5, 52.6, 
49.1, 45.5, 37.9, 18.5. ESI-MS: (M+H)+ m/z 447. 
(B) Synthesis of 2g 
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2g was synthesized according to the previous report (Alberti et al., 2009). 
To a solution of Boc-L-serine (5.1 g, 25 mmol) in 100 mL of CH2Cl2 was added phenylalanine 
methyl ester hydrochloride (6.45 g, 30 mmol), followed by the addition of triethylamine (TEA) 
(7.5 mL, 50 mmol) and HBTU (11.4 g, 30 mmol). The mixture was stirred at room temperature 
overnight. The solvent was evaporated and the residue was dissolved in EtOAc (200 mL). The 
organic phase was washed with saturated citric acid (150 mL) and saturated aq. NaHCO3 (150 mL) 
and then dried over anhydrous Na2SO4, filtered, and concentrated in vacuo. The residue was 
purified by flash silica gel column chromatography (petroleum ether/EtOAc, 1:1) affording 
product P3 as colorless oil (5.94 g, 65 % yield).  
To a solution of P3 (6.31 g, 17.24 mmol) in 20 mL of CH2Cl2 was added 5 mL of TFA dropwise 
at 0°C, and the solution was stirred at room temperature for 3 h. The solvent was evaporated and 
the white residue was recrystallized affording product P4 as a white solid (5.13 g, 82 % yield).   
Sodium metaperiodate (1.015 g, 5.50 mmol) was added to a solution of peptide P4 (1.0 g, 2.75 
mmol) in 25 mM sodium phosphate buffer (pH 7.0) (5 mL). The solution was stirred at room 
temperature in the dark for 30 min. TLC revealed that no P4 was remained. The solution was 
extracted with EtOAc (3 × 25 mL), and the combined organic phase was concentrated in vacuo. 
The residue was purified by flash silica gel column chromatography (petroleum ether/EtOAc, 1:1) 
to provide product 2g as a colorless oil (380 mg, 59%). 
 
3. General procedures for the visible-light photoredox olefination 
General procedures for visible-light photoredox synthesis of terminal alkenes (3) 
[Ru(bpy)3]Cl2•6H2O (A) (3.8 mg, 5.0 μmol) or [Ir(ppy)2]dtbbpyPF6 (C) (4.6 mg, 5.0 µmol), alkyl 
bromide (1) (1.0 mmol) (if solid), paraformaldehyde (2a) (4.0 mmol for synthesis of 3n-p; 2.0 
mmol for synthesis of the others, relative to amount of formaldehyde) or aqueous formaldehyde 
(37% aqueous solution) (2b) (2.0 mmol), triphenylphosphine (PPh3) (786 mg, 3.0 mmol for 
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synthesis of 3n-p; 393 mg, 1.5 mmol for synthesis of the others), K2CO3 (414 mg, 3.0 mmol for 
synthesis of 3n-p; 207 mg, 1.5 mmol for synthesis of the others), MeCN (10 mL) were added to a 
25 mL Schlenk tube equipped with a magnetic stir bar, and then the mixture was bubbled with 
argon through a syringe needle for 5 min. Alkyl halides (1.0 mmol) (if liquid) was added to the 
mixture under argon flow. The tube was sealed, and then irradiated with a 23 W fluorescent bulb 
(the tube was approximately 2.5 cm away from the light source) at room temperature (~25 oC) in a 
fume hood with fast stream of air. After completion of the reaction, 20 mL of water was added to 
the resulting solution, and the solution was exacted with diethyl ether (3 × 20 mL). The combined 
organic phase was concentrated by rotary evaporator, and the residue was purified by silica gel 
column chromatography to give the desired product (3). 
General procedures for visible-light photoredox synthesis of substituted 
3,3,3-trifluoropropenes (4) 
Ru(bpy)3Cl2·6H2O (3.8 mg, 5.0 μmol) or [Ir(ppy)2dtbbpy]PF6 (4.6 mg, 5.0 μmol), K2CO3 (414 mg, 
3.0 mmol for synthesis of 4j and 4k; 207 mg, 1.5 mmol for synthesis of the others), PPh3 (786 mg, 
3.0 mmol for synthesis of 4j and 4k; 393 mg, 1.5 mmol for synthesis of the others), alkyl halide 
(1.0 mmol) (if solid) and CH3CN (10 mL) were added to a 25 mL Schlenk tube equipped with a 
magnetic stir bar, and then the mixture was bubble with argon through a syringe needle for 5 min. 
Alkyl halides (1.0 mmol) (if liquid), 2,2,2-trifluoroacetaldehyde hydrate (75% aqueous solution) 
(2c) (2.2 mmol for synthesis of 4j and 4k; 1.1 mmol for synthesis of the others) or 
2,2,2-trifluoro-1-methoxyethanol (2d) (1.1 mmol) were added to the mixture under argon flow. 
The tube was sealed, and then irradiated with a 23 W fluorescent bulb (the tube was approximately 
2.5 cm away from the light source) at room temperature (~25 oC) in a fume hood with fast stream 
of air. After completion of the reaction, 20 mL of water was added to the resulting solution, and 
the solution was exacted with diethyl ether (3 × 20 mL). The combined organic phase was 
concentrated by rotary evaporator, and the residue was purified by silica gel column 
chromatography to give the desired product (4). 
General procedures for visible-light photoredox olefination leading to internal alkenes (5) 
[Ru(bpy)3]Cl2•6H2O (A) (3.8 mg, 5.0 μmol) or [Ir(ppy)2]dtbbpyPF6 (C) (9.1 mg, 10 μmol), K2CO3 
(207 mg, 1.5 mmol), PPh3 (393 mg, 1.5 mmol), alkyl bromide (1) (1.5 mmol) (if solid), aldehydes 
(1.2 mmol) and DMF (2.0 mL) were added to a 25 mL Schlenk tube equipped with a magnetic stir 
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bar, and then the mixture was bubble with argon through a syringe needle for 5 min. Alkyl halides 
(1.5 mmol) (if liquid) was added to the mixture under argon flow. The tube was sealed, and then 
irradiated with a 23 W fluorescent bulb (the tube was approximately 2.5 cm away from the light 
source) at room temperature (~25 oC) in a fume hood with fast stream of air. After completion of 
the reaction, 20 mL of water was added to the resulting solution, and the solution was exacted with 
diethyl ether (3 × 20 mL). The combined organic phase was concentrated by rotary evaporator, 
and the residue was purified by silica gel column chromatography to give the desired product (5). 
4. Gram scale synthesis 
 
 
 
 
 
 
 
 
                                   
Figure S231 | Procedures for gram scale synthesis 
(1) Gram scale synthesis of 1-bromo-4-vinylbenzene (3i), related to Figure 2. 4-Bromobenzyl 
bromide (1a) (5 g, 20 mmol), paraformaldehyde (2a) (1.2 g, 40 mmol), [Ru(bpy)3]Cl2•6H2O (A) 
(37.4 mg, 50 μmol), PPh3 (7.86 g, 30 mmol) and K2CO3 (4.08 g, 30 mmol) were added to a 100 
a b 
c d 
f e 
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mL rounded bottom bottle (Fig. S231-a), then 60 mL of DMF was added to the bottle, and the 
mixture was bubbled with Ar for 20 min (Fig. S231-b). The bottle was sealed and was irradiated 
with 2 × 23 W fluorescent lamp (approximately 4 cm away from the light source) at room 
temperature (~25 oC) in a fume hood with fast stream of air for 12 h (Fig. S231-c). After the 
reaction completed, the mixture colour was changed from orange to brown (Fig. S231-d). The 
resulting mixture was determined by TLC using hexane as the eluent (Fig. S231-e). The reaction 
was quenched with water (100 mL), and the aqueous solution was extracted with diethyl ether 
(3×100 mL). The combined organic phase was evaporated under reduced pressure, and the residue 
was purified with silica gel column chromatography to get the desired product (3i) (3.33 g, 90%) 
(Fig. S1-f). 
(2) Gram scale synthesis of (E)-1-Chloro-4-styrylbenzene (5i): 4-Chlorobenzaldehyde (2h) 
(14.06 g, 100 mmol), [Ru(bpy)3]Cl2•6H2O (A) (74.8 mg, 100 μmol), PPh3 (39.3 g, 150 mmol), 
K2CO3 (20.4 g, 150 mmol) and DMF (200 mL) were added to a 500 mL rounded bottom bottle, 
and the mixture was bubbled with Ar for 20 min. Benzyl bromide (1b) (14.4 mL, 120 mmol) was 
added to the mixture under Ar. The bottle was sealed and irradiated with 2 × 23W fluorescent 
lamp (approximately 4 cm away from the light source) at room temperature (~25 oC) in a fume 
hood with fast stream of air for 36 h. The reaction was quenched with water (200 mL), and the 
resulting solution was extracted with diethyl ether (3 × 200 mL). The combined organic phase was 
dried over anhydrous Na2SO4 and evaporated under reduced pressure, and the residue was purified 
with silica gel column chromatography to get the desired product (5i) (19.54 g, 91%). 
 
5. Mechanism study 
(1) Synthesis and reaction of 18O-labelled benzaldehyde (2j) 
 
Benzaldehyde dimethyl acetal (304 mg, 2 mmol), dry CH3CN (2 mL) were added to a 5 mL round 
bottom bottle, and then H2O18 (60 μL, 3 mmol) and MeSO3H (384 mg, 4 mmol) were added to the 
bottle under Ar. The mixture was stirred overnight under Ar at room temperature, then the solvent 
was removed, and the residue was purified by silica gel column chromatography to get the 
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18O-labelled benzaldehyde (2j), 194.5 mg (90%). 1H NMR (CDCl3, 400 MHz) 10.0 (s, 1H), 7.88 
(d, J = 7.56 Hz, 2H), 7.63 (t, J = 7.56 Hz, 1H), 7.53 (t, J = 7.56 Hz, 2H). 13C NMR (CDCl3, 100 
MHz) 187.9, 137.1, 130.0, 135.3, 129.0. EIMS: M+ m/z 108. 
 
 
Reaction of 18O-labeled benzaldehyde (2j) with 4-methylbenzyl bromide (1e) was performed 
under the standard conditions. 18O-labeled triphenylphosphine-oxide (7) was obtained in 91% 
yield (254 mg) as a white solid. 1H NMR (CDCl3, 400 MHz) 7.66-7.61 (m, 2H), 7.52-7.48 (m, 
1H), 7.44-7.40 (m, 2H). 13C NMR (CDCl3, 100 MHz) 133.1, 132.2, 132.1, 132.0, 128.6, 128.5. 
HRMS (ESI-TOF) calculated for C18H16P18O [M+H]+ m/z 281.0998, found 281.1002.  
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(2) Treatment of (4-methylbenzyl)triphenylphosphonium bromide (6) with 
4-methylphenyldehyde (2i) under the standard conditions 
 
Treatment of 4-methylphenyldehyde (2i) (120 mg, 1.0 mmol) with a fresh synthesized 
(4-methylbenzyl)triphenylphosphonium bromide (6) (536 mg, 1.2 mmol) was performed with 0.5 
mol% catalyst Ru(bpy)3Cl2•6H2O (A) or [Ir(ppy)2dtbbpy]PF6 (C) as the photocatalyst under the 
standard conditions. After irradiation with 23 W CFL for 24 h, only trace amounts of 
(E)-1,2-dip-tolylethene (5ai) were observed. The same result was obtained when addition an 
additional equivalent of PPh3. The result indicated that the mechanism in Fig. 3-5 was not a 
traditional Wittig coupling. 
(3) Treatment of 18O-labelled benzaldehyde (2j) with triphenylphosphine or 
triphenylphosphine and 1,1-diphenylethylene (8) 
 
Treatment of 18O-labelled benzaldehyde (2j) with triphenylphosphine (in the absence of alkyl 
halide) was performed under the standard reaction conditions for 24 h, and no 18O-labeled 
triphenylphosphine oxide (7) was found. Subsequently, we investigated reaction of 18O-labelled 
benzaldehyde (2j), triphenylphosphine and 1,1-diphenylethylene (8), and  7 and 9 were not 
observed.  
(4) Treatment of 4-methylbenzyl bromide (1e) with triphenylphosphine 
 
Treatment of 4-methylbenzyl bromide (1e) (1.0 mmol) with PPh3 (1.0 mmol) (in the absence of 
aldehyde and base) was carried out under the standard conditions for 1 h, and (4-methylbenzyl)
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triphenylphosphonium bromide (6) was obtained in 94% yield (see Fig. S233). A control 
experiment in the absence of visible light was performed, and only small amounts of 6 were 
observed.  
 
Figure S232 | Procedures for control experiment on reaction of 4-methylbenzyl bromide (1e) with PPh3 
under standard conditions (in the absence of aldehyde and base), related to Figure 1. (a) 4-methylbenzyl 
bromide (1e) (250 mg, 1 mmol) , PPh3 (262.3 mg, 1 mmol) and [Ru(bpy)3]Cl2•6H2O (A) (3.8 mg, 5.0 μmol) were 
added to a 25 mL Schlenk tube; (b) After CH3CN (6 mL) was added to the tube, the mixture was bubbled with Ar 
through a needle for over 5 min; (c) The tube was sealed, and small amounts of PPh3 remained undissolved; (d) 
The tube was irradiated with a 23 W CFL bulb (the tube was approximately 2.5 cm away from the light source) at 
room temperature (~25 oC) in a fume hood with fast stream of air. 5 min later, all PPh3 was dissolved, and the 
color changed into dark red from orange; (e) After the mixture was irradiated for 1 h, a white precipitation (4-
methylbenzyl)triphenylphosphonium bromide (6) appeared.  
 
(5) Electron spin resonance (ESR) determination conditions and HRMS of the intermediates 
Electron spin resonance (ESR) experiment was recorded on an X-band JES FA200 (JEOL CO.). 
The experimental conditions are as follows: frequency 9.068 GHz, power 1 mW, center field 
a b
 
c 
d e 
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323.124 mT, sweep width 10 mT, modulation width 0.1 mT, sweep time 1 min, time constant 0.1 
s. 
 
Figure S233 | ESR spectra of the radicals trapped by DMPO under different conditions: ESR spectra of the 
radicals trapped by DMPO under different conditions (every experiment was performed in the presence of 
K2CO3 as the base), related to Figure 1. (a) 4-Methyl benzyl bromide (1e) (50 mM), DMPO (100 mM), 
[Ru(bpy)3]Cl2•6H2O (0.5 mM) in CH3CN irradiated with a 23 W CFL bulb for 5 min; (b) 4-Methylbenzaldehyde 
(2i) (50 mM), DMPO (100 mM), [Ru(bpy)3]Cl2•6H2O (0.5 mM) in CH3CN irradiated with a 23 W CFL bulb for 5 
min; (c) Triphenylphosphine (50 mM), DMPO (100 mM), [Ru(bpy)3]Cl2•6H2O (0.5 mM) in CH3CN irradiated 
with a 23 W CFL bulb for 5 min; (d) 4-Methylbenzaldehyde (2i) (50 mM), triphenylphosphine (50 mM), DMPO 
(100 mM), [Ru(bpy)3]Cl2•6H2O (0.5 mM) in CH3CN irradiated with a 23 W CFL bulb for 5 min; (e) 4-Methyl 
benzyl bromide (1e) (50 mM), triphenylphosphine (50 mM), DMPO (100 mM), [Ru(bpy)3]Cl2•6H2O (0.5 mM) in 
CH3CN irradiated with a 23 W CFL bulb for 5 min; (f) 4-Methyl benzyl bromide (1e) (50 mM), 
4-methylbenzaldehyde (2i) (50 mM), DMPO (100 mM), [Ru(bpy)3]Cl2•6H2O (0.5 mM) in CH3CN irradiated with 
a 23 W CFL bulb for 5 min; (g) 4-Methyl benzyl bromide (1e) (50 mM), 4-methylbenzaldehyde (2i) (50 mM), 
DMPO (100 mM), triphenylphosphine (50 mM), [Ru(bpy)3]Cl2•6H2O (0.5 mM) in CH3CN irradiated with a 23 W 
CFL bulb for 5 min. 
In order to explore mechanism for the visible-light photoredox olefination, we investigated 
which types of radicals were produced during the reactions by electron spin resonance (ESR). (a) 
A mixture of 4-methyl benzyl bromide (1e), 5,5-dimethyl-1-pyrroline N-oxide (DMPO) and 
photocatalyst [Ru(bpy)3]Cl2•6H2O in CH3CN was bubbled with Ar for 5 min, and the mixture was 
transferred to a quartz flat cell and irradiated with a 23 W CFL bulb for 5 min. The resulting 
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solution was tested by ESR, and no signal was observed (Fig. S233-a), which showed that the 
direct reduction of 4-methylbenzaldehyde (2i) is thermodynamically unfavoured. Subsequently, 
the similar procedures were performed in the following experiments. (b) No signal appeared in 
ESR spectrum of mixture of 4-methylbenzaldehyde (2i), DMPO and [Ru(bpy)3]Cl2•6H2O in 
CH3CN (Fig. S233-b). (c) ESR super-hyperfine spectrum of mixture of triphenylphosphine, 
DMPO, [Ru(bpy)3]Cl2•6H2O in CH3CN exhibited a signal of nitrogen-centred DMPO radical 
adduct I-A (see Fig. S234-c) (g = 2.005, AN = 1.38 mT, AH = 1.40 mT) (Fig. S233-c), and no 
phosphorus-centred DMPO radical adduct (AH = 2.9 mT) (Alberti et al., 2009) was observed, 
which is attributed to quick reaction of triphenylphosphine cation radical with DMPO to generate 
a nitrogen-centred radical (see Fig. S234-c). (d) For mixture of 4-methylbenzaldehyde (2i), 
triphenylphosphine, DMPO, [Ru(bpy)3]Cl2•6H2O in CH3CN, similar signal was observed (Fig. 
S3-d), which indicated that 4-methylbenzaldehyde (2i) did not participate in the radical reaction. 
(e) ESR spectrum of mixture of 4-methylphenyl bromide (1e), triphenylphosphine and 
photocatalyst [Ru(bpy)3]Cl2•6H2O provided a weak signal of C-centred DMPO radical adduct I-E 
(found in HRMS) (see Fig. S234-e) (g = 2.003, AN = 1.48 mT, AH = 2.02 mT) (Bunik et al., 2002) 
(Fig. S233-e). Comparing the results in Fig. S232-a and S232-e, we speculate that PPh3 radical 
cation can form a charge-transfer complex with the benzyl bromide, which facilitates the reduction 
by Ru(I) (see Fig. S234-e). (f) Surprisingly, ESR spectrum of mixture of 4-methylphenyl bromide 
(1e), 4-methylbenzaldehyde (2i) and photocatalyst [Ru(bpy)3]Cl2•6H2O gave a weak sextet signal 
of oxygen-centred DMPO radical adduct I-G (see Fig. S234-f) (g = 2.003, AN= 1.34 mT, AH =1.15 
mT) (Dikalov et al., 2001) (Fig. S233-f). A possible explanation is that formation of complex of 
I-H in Fig. S234-f with 1e promotes reduction of 1e by Ru(II), and subsequent treatment of benzyl 
radical with aldehyde 2i gives oxygen-centred radical (see Fig. S234-f). (g) When all reagents 
appeared in the reaction system, a strong signal from carbon-centred DMPO radical adduct I-E 
was observed with a signal from nitrogen-centred DMPO radical adduct I-A appearing (see Fig. 
S233-g and S234-g). The results above indicate that the process for the visible-light photoredox 
olefination in Fig. 2 is reasonable. This report is the first example of broadly applicable reduction 
of simple benzyl halides by visible light photoredox catalysis, and more detailed mechanistic 
studies are underway to better understand this key step in the catalytic cycle. The intermediates 
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mentioned above I-A, I-E and I-G were detected by HRMS, I-E was found ([M+H]: calculated 
219.2623, found 219.1626), but I-A, I-G were not found in HRMS. 
 
Figure S234 | Formation of various DMPO radical adducts, related to Figure 1. 
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Figure S235 | HRMS of DMPO radical adducts, related to Figure 1. 
 
(6) The CV (Cylic Voltammetry) of the reactants in DMF 
 
Figure S236 | Reaction of 1e with 2j in the presence of TEMPO or BHT, related to Figure 1. 
We attempted reaction of 1e with 2j in the presence of TEMPO or BHT (2 equiv), and only trace 
amount of 5b was observed. The results showed that the reaction underwent a radical process. 
 
 
 
 
 
 
 
 
 
N
O I-E
[M+H] Calculated: 219.1623 
Found: 219.1626 
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(7) The CV (Cylic Voltammetry) of the reactants in DMF 
 
Figure S237. The CV of p-Tolualdehyde (0.1M) in 0.1M nBu4NPF6 in DMF at a Pt working electrode with a 
Pt counter electrode and Ag wire quasireference, related to Figure 1. Potential sweep rate was 50 mV/s. 
 
Figure S238 The CV of Triphenylphosphine (0.1M) in 0.1M nBu4NPF6 in DMF at a Pt working electrode 
with a Pt counter electrode and Ag wire quasireference, related to Figure 1. Potential sweep rate was 50 mV/s. 
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Figure S239. The CV of Ru(bpy)3Cl2 (0.1M) in 0.1M nBu4NPF6 in DMF at a Pt working electrode with a Pt 
counter electrode and Ag wire quasireference, related to Figure 1. Potential sweep rate was 50 mV/s. 
 
Figure S240. The CV of 4-Methylbenzyl bromide (0.1M) in 0.1M nBu4NPF6 in DMF at a Pt working 
electrode with a Pt counter electrode and Ag wire quasireference, related to Figure 1. Potential sweep rate 
was 50 mV/s. 
The Cyclic Voltammetry experiment shows that the electron can transfer from triphenylphophine to photocatalyst 
Ru(bpy)3Cl2 easily, while can hardly to aldehydes.   
 
6. Characterization data of compounds 3, 4 and 5 
 3a 
Styrene (3a) (related to Figure 2) (Gärtner et al., 2015): Eluent: pentane, the solvent was removed 
at 0 ℃ under reduced pressure. Yield: X=Br, 70 mg (67%) with 2a as the reactant, 64.8 mg (62%) 
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with 2b as the reactant; X=Cl, 54.2 mg (52%) with 2a as the reactant. Colorless oil. 1H NMR 
(CDCl3, 400 MHz) δ 7.41 (d, J = 6.87 Hz, 2H), 7.32 (t, J = 6.87 Hz, 2H), 7.24 (t, J = 6.87 Hz, 1H), 
6.72 (dd, J1 = 17.40 Hz, J2 = 10.99 Hz, 1H), 5.75 (d, J = 18.78 Hz, 1H), 5.24 (d, J = 10.99 Hz, 1H). 
13C NMR (CDCl3, 100 MHz) δ 137.7, 137.0, 128.6, 127.9, 126.3, 113.9. EI-MS: M+ m/z 104. 
Me  3b 
1-Methyl-4-vinylbenzene (3b) (related to Figure 2) (Gärtner et al., 2015): Eluent: pentane, the 
solvent was removed at 0 ℃ under reduced pressure. Yield: X=Br, 89.7 mg (76%) with 2a as the 
reactant, 82.6 mg (70%) with 2b as the reactant; X=Cl, 56.6 mg (48%) with 2a as the reactant. 
Colorless oil. 1H NMR (CDCl3, 400 MHz) δ 7.33 (d, J = 8.24 Hz, 2H), 7.16 (d, J = 7.79 Hz, 2H), 
6.72 (dd, J1 = 17.40 Hz, J2 = 10.99 Hz, 1H), 5.72 (d, J = 17.40 Hz, 1H), 5.21 (d, J = 10.99 Hz, 1H), 
2.37 (s, 3H). 13C NMR (CDCl3, 100 MHz) δ 137.7, 136.8, 135.0, 129.3, 126.3, 112.9, 21.3. EI-MS: 
M+ m/z 118. 
 3c 
1-Vinylnaphthalene (3c) (related to Figure 2) (Zhang et al., 2016): Eluent: pentane. Yield: 138.7 
mg (90%). Colorless oil. 1H NMR (CDCl3, 400 MHz) δ 8.19 (d, J = 7.79 Hz, 1H), 7.92 (d, J = 
7.79 Hz, 1H), 7.85 (d, J = 8.24 Hz, 1H), 7.70 (d, J = 7.33 Hz, 1H), 7.60-7.50 (m, 4H), 5.87 (d, J = 
17.40 Hz, 1H), 5.55 (d, J = 10.53 Hz, 1H). 13C NMR (CDCl3, 100 MHz) δ 135.7, 134.5, 133.7, 
131.2, 128.6, 128.2, 126.2, 125.9, 125.7, 123.9, 123.7. EI-MS: M+ m/z 154. 
MeO
OMe  3d 
1,3-Dimethoxy-5-vinylbenzene (3d) (related to Figure 2) (Cao et al., 2014): Eluent: pentane. Yield: 
147.7 mg (90%). Colorless oil. 1H NMR (CDCl3, 400 MHz) δ 6.73 (dd, J1 = 17.63 Hz, J2 = 10.99 
Hz, 1H), 6.66 (s, 2H), 6.48 (s, 1H), 5.81 (d, J = 17.86 Hz, 1H), 5.32 (d, J = 10.99 Hz, 1H), 3.84 (s, 
6H). 13C NMR (CDCl3, 100 MHz) δ 161.0, 139.6, 136.9, 114.3, 104.3, 100.1, 55.3. EI-MS: M+ 
m/z 154. 
F
 3e 
1-Fluoro-3-vinylbenzene (3e) (related to Figure 2) (Wienhöfer et al., 2012): Eluent: pentane, the 
solvent was removed at 0 ℃ under reduced pressure. Yield: 91.6 mg (75%). Colorless oil. 1H 
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NMR (CDCl3, 400 MHz) δ 7.29-7.23 (m, 1H), 7.16-7.09 (m, 2H), 6.94 (t, J = 8.24 Hz, 1H), 6.67 
(dd, J1 = 17.40 Hz, J2 = 10.99 Hz, 1H), 5.75 (d, J = 17.86 Hz, 1H), 5.29 (d, J = 10.99 Hz, 1H). 19F 
(CDCl3, 376.5 MHz) δ -112.4. 13C NMR (CDCl3, 100 MHz) δ 163.2 (JF-C = 245.37 Hz), 140.0 
(JF-C = 7.67 Hz), 136.0, 130.1 (JF-C = 8.63 Hz), 122.3 (JF-C = 2.88 Hz), 115.3, 114.7 (JF-C = 22.04 
Hz), 112.8 (JF-C = 21.09 Hz). EI-MS: M+ m/z 122. 
F  3f 
1-Fluoro-4-vinylbenzene (3f) (related to Figure 2) (Gärtner et al., 2015): Eluent: pentane, the 
solvent was removed at 0 ℃ under reduced pressure. Yield: 94.0 mg (77%). Colorless oil. 1H 
NMR (CDCl3, 400 MHz) δ 7.38-7.35 (m, 2H), 7.01 (t, J = 8.70 Hz, 2H), 6.67 (dd, J1 = 17.63 Hz, 
J2 = 10.99 Hz, 1H), 5.67 (d, J = 17.86 Hz, 1H), 5.23 (d, J = 10.99 Hz, 1H). 19F (CDCl3, 376.5 
MHz) δ -114.3. 13C NMR (CDCl3, 100 MHz) δ 162.6 (JF-C = 247.28 Hz), 135.8, 133.9 (JF-C = 3.83 
Hz), 127.9 (JF-C = 7.67 Hz), 115.5 (JF-C = 22.04 Hz), 113.6. EI-MS: M+ m/z 122. 
Br
 3g 
1-Bromo-2-vinylbenzene (3g) (related to Figure 2) (Zhang et al., 2016): Eluent: pentane, the 
solvent was removed at 0 ℃ under reduced pressure. Yield: 142 mg (78%) with 2a as the 
reactant, 138.36 mg (76%) with 2b as the reactant. Colorless oil. 1H NMR (CDCl3, 400 MHz) δ 
7.53 (d, J = 8.24 Hz, 2H), 7.26 (t, J = 7.33 Hz, 1H), 7.12-7.02 (m, 2H), 5.69 (d, J = 17.40 Hz, 1H), 
5.35 (d, J = 10.99 Hz, 1H). 13C NMR (CDCl3, 100 MHz) δ 137.6, 135.9, 133.0, 129.2, 127.6, 
126.9, 123.7, 116.8. EI-MS: M+ m/z 182. 
Br
 3h 
1-Bromo-3-vinylbenzene (3h) (related to Figure 2) (Planellas et al., 2014): Eluent: pentane, the 
solvent was removed at 0 ℃ under reduced pressure. Yield: 162.9 mg (89%). Colorless oil. 1H 
NMR (CDCl3, 400 MHz) δ 7.56 (s, 1H), 7.53 (d, J = 8.24 Hz, 2H), 7.39 (d, J = 7.79 Hz, 1H), 7.32 
(d, J = 7.79 Hz, 1H), 7.20 (t, J = 7.79 Hz, 1H), 6.65 (dd, J1 = 17.63 Hz, J2 = 10.99 Hz, 1H), 5.76 
(d, J = 17.40 Hz, 1H), 5.30 (d, J = 10.99 Hz, 1H). 13C NMR (CDCl3, 100 MHz) δ 139.8, 135.6, 
130.8, 130.2, 129.3, 125.0, 122.9, 115.5. EI-MS: M+ m/z 182. 
Br  3i 
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1-Bromo-4-vinylbenzene (3i) (related to Figure 2) (Zhang et al., 2016): Eluent: pentane, the 
solvent was removed at 0 ℃ under reduced pressure. Yield: X=Br, 167.5 mg (92%) with 2a as 
the reactant, 161.2 mg (89%) with 2b as the reactant; X=Cl, 111.0 mg (61%) with 2a as the 
reactant. Colorless oil. 1H NMR (CDCl3, 400 MHz) δ 7.43 (d, J = 8.70 Hz, 2H), 7.26 (d, J = 8.70 
Hz, 2H), 6.64 (dd, J1 = 17.63 Hz, J2 = 10.99 Hz, 1H), 5.73 (d, J = 17.40 Hz, 1H), 5.27 (d, J = 
10.99 Hz, 1H). 13C NMR (CDCl3, 100 MHz) δ 136.6, 135.9, 131.7, 127.9, 121.7, 114.7. EI-MS: 
M+ m/z 182. 
CF3
 3j 
1-(Trifluoromethyl)-2-vinylbenzene (3j) (related to Figure 2) (Planellas et al., 2014): Eluent: 
pentane, the solvent was removed at 0 ℃ under reduced pressure. Yield: 123.9 mg (72%). 
Colorless oil. 1H NMR (CDCl3, 400 MHz) δ 7.65 (t, J = 8.70 Hz, 2H), 7.52 (t, J = 7.79 Hz, 1H), 
7.36 (t, J = 7.79 Hz, 1H), 7.16-7.08 (m, 1H), 5.75 (d, J = 16.94 Hz, 1H), 5.43 (d, J = 10.99 Hz, 
1H). 19F (CDCl3, 376.5 MHz) δ -59.4. 13C NMR (CDCl3, 100 MHz) δ 136.9, 133.2, 132.0, 127.6, 
127.5 (JF-C = 29.71 Hz), 127.2, 125.8 (JF-C = 5.75 Hz), 123.1, 118.1. EI-MS: M+ m/z 172. 
CN
 3k 
2-Vinylbenzonitrile (3k) (related to Figure 2) (Xu et al., 2008): Eluent: hexane/ethyl acetate 10:1. 
Yield: 116.2 mg (90%). Colorless oil. 1H NMR (CDCl3, 400 MHz) δ 7.66 (d, J = 8.24 Hz, 1H), 
7.60 (d, J = 7.33 Hz, 1H), 7.54 (t, J = 7.79 Hz, 1H), 7.32 (t, J = 8.70 Hz, 1H), 7.06 (dd, J1 = 17.40 
Hz, J2 = 10.99 Hz, 1H),  5.93 (d, J = 17.40 Hz, 1H), 5.52 (d, J = 10.99 Hz, 1H). 13C NMR 
(CDCl3, 100 MHz) δ 140.7, 132.9, 128.9, 128.8, 128.0, 125.5, 119.0, 117.8, 111.2. EI-MS: M+ m/z 
129. 
NC  3l 
4-Vinylbenzonitrile (3l) (related to Figure 2) (Gärtner et al., 2015): Eluent: hexane/ethyl acetate 
10:1. Yield: X=Br, 114.9 mg (89%) with 2a as the reactant, 112.3 mg (87%) with 2b as the 
reactant; X=Cl, 83.9 mg (65%) with 2a as the reactant. Light yellow oil. 1H NMR (CDCl3, 400 
MHz) δ 7.59 (d, J = 8.24 Hz, 2H), 7.46 (d, J = 8.24 Hz, 2H), 6.70 (dd, J1 = 17.86 Hz, J2 = 10.99 
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Hz, 1H), 5.93 (d, J = 17.86 Hz, 1H), 5.43 (d, J = 10.99 Hz, 1H). 13C NMR (CDCl3, 100 MHz) δ 
141.9, 135.4, 132.4, 126.8, 119.0, 117.8, 111.1. EI-MS: M+ m/z 129. 
N  3m 
3-Vinylpyridine (3m) (related to Figure 2) (Gärtner et al., 2015): Eluent: pentane/CH2Cl2 3:1, the 
solvent was removed at 0 ℃ under reduced pressure. Yield: 70.4 mg (67%). Yellow oil. 1H NMR 
(CDCl3, 400 MHz) δ 8.61 (s, 1H), 8.48 (d, J = 6.41 Hz, 1H), 7.73 (d, J = 8.79 Hz, 1H), 7.28-7.24 
(m, 1H), 6.70 (dd, J1 = 17.86 Hz, J2 = 10.99 Hz, 1H), 5.83 (d, J = 17.86 Hz, 1H), 5.38 (d, J = 
10.99 Hz, 1H). 13C NMR (CDCl3, 100 MHz) δ 148.9, 148.3, 133.5, 133.1, 132.8, 123.5, 116.3. 
EI-MS: M+ m/z 105. 
3o 
1,2-Divinylbenzene (3o) (related to Figure 2) (Tanaka et al., 2008): Eluent: pentane, the solvent 
was removed at 0 ℃ under reduced pressure. Yield: 114.5 mg (88%). Colorless oil. 1H NMR 
(CDCl3, 400 MHz) δ 7.46-7.43 (m, 2H), 7.25-7.23 (m, 2H), 7.01 (dd, J1 = 17.40 Hz, J2 = 10.99 Hz, 
2H), 5.62 (d, J = 17.40 Hz, 2H), 5.32 (d, J = 10.99 Hz, 2H). 13C NMR (CDCl3, 100 MHz) δ 136.2, 
134.9, 127.9, 126.4, 116.5. EI-MS: M+ m/z 130. 
3n 
1,3-Divinylbenzene (3n) (related to Figure 2) (Tanaka et al., 2008): Eluent: pentane, the solvent 
was removed at 0 ℃ under reduced pressure. Yield: 117.1 mg (90%). Colorless oil. 1H NMR 
(CDCl3, 400 MHz) δ7.45 (s, 1H), 7.35-7.28 (m, 3H), 6.74 (dd, J1 = 17.40 Hz, J2 = 10.99 Hz, 2H), 
5.79 (d, J = 17.40 Hz, 2H), 5.28 (d, J = 10.99 Hz, 2H). 13C NMR (CDCl3, 100 MHz) δ 137.9, 
136.9, 128.8, 125.7, 124.4, 114.2. EI-MS: M+ m/z 130. 
3p 
1,4-Divinylbenzene (3p) (related to Figure 2) (Tanaka et al., 2008): Eluent: pentane, the solvent 
was removed at 0 ℃ under reduced pressure. Yield: 118.4 mg (91%). Colorless oil. 1H NMR 
(CDCl3, 400 MHz) δ 7.40 (s, 4H), 6.74 (dd, J1 = 17.40 Hz, J2 = 10.99 Hz, 2H), 5.78 (d, J = 17.40 
Hz, 2H), 5.27 (d, J = 10.99 Hz, 2H). 13C NMR (CDCl3, 100 MHz) δ 137.2, 136.6, 126.5, 113.9. 
EI-MS: M+ m/z 130. 
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H
N
O
Me 3q 
N-p-Tolyl-4-vinylbenzamide (3q) (related to Figure 2) (Pogosyan et al., 1979): Eluent: 
hexane/ethyl acetate 5:1. Yield: 215.7 mg (91%). White solid, mp. 182-183 ℃. 1H NMR (CDCl3, 
400 MHz) δ 7.82 (d, J = 7.33 Hz, 2H), 7.53-7.46 (m, 4H), 7.16 (d, J = 8.24 Hz, 2H), 6.75 (dd, J1 = 
17.40 Hz, J2 = 10.99 Hz, 1H), 5.85 (d, J = 17.40 Hz, 1H), 5.38 (d, J = 10.99 Hz, 1H), 2.34 (s, 3H). 
13C NMR (CDCl3, 100 MHz) δ 165.4, 141.0, 136.0, 135.5, 134.4, 134.2, 129.7, 127.5, 126.6, 
120.4, 116.3, 21.0. ESI-MS: [M+H]+ m/z 238. 
H
N
O
MeOOC
Ph 3r 
(S)-Methyl 3-phenyl-2-(4-vinylbenzamido)propanoate (3r) (related to Figure 2) (Poulsen et al., 
2006): Eluent: hexane/ethyl acetate 5:1. Yield: 278.2 mg (90%). Colorless solid, mp. 56-57 ℃. 1H 
NMR (CDCl3, 400 MHz) δ 7.69 (d, J = 8.24 Hz, 2H), 7.44 (d, J = 8.24 Hz, 2H), 7.31-7.25 (m, 3H), 
7.13 (d, J = 8.24 Hz, 2H), 6.73 (dd, J1 = 17.63 Hz, J2 = 10.99 Hz, 1H), 6.60 (d, J = 7.33 Hz, 1H), 
5.83 (d, J = 16.94 Hz, 1H), 5.35 (d, J = 11.45 Hz, 1H), 5.09 (dd, J1 = 13.05 Hz, J2 = 5.95 Hz, 1H), 
3.76 (s, 3H), 3.32-3.20 (m, 2H). 13C NMR (CDCl3, 100 MHz) δ 172.2, 166.5, 141.1, 136.0, 135.9, 
133.0, 129.5, 128.7, 127.4, 127.3, 126.5, 116.2, 53.6, 52.6, 38.0. ESI-MS: [M+H]+ m/z 310. 
H
N
O
Ph
O
N
H
MeOOC
3s 
(S)-Methyl 3-methyl-2-((S)-3-phenyl-2-(4-vinylbenzamido)propanamido)butanoate (3s) (related 
to Figure 2): Eluent: hexane/ethyl acetate 2:1. Yield: 330.5 mg (81%). White solid. 1H NMR 
(CDCl3, 400 MHz) δ 7.69 (d, J = 8.24 Hz, 2H), 7.41 (d, J = 8.24 Hz, 2H), 7.27-7.08 (m, 6H), 
6.79-6.68 (m, 2H), 5.82 (d, J = 17.86 Hz, 1H), 5.35 (d, J = 10.53 Hz, 1H), 5.00 (m, 1H),4.44 (dd, 
J1 = 8.47 Hz, J2 = 5.50 Hz, 1H), 3.71 (s, 3H), 3.26-3.15 (m, 2H), 2.13-2.05 (m, 1H), 0.83 (dd, J1 = 
9.16 Hz, J2 = 6.87 Hz, 1H). 13C NMR (CDCl3, 100 MHz) δ 171.8, 171.2, 167.0, 141.0, 136.7, 
136.0, 132.9, 129.5, 128.7, 127.6, 127.1, 126.4, 116.2, 57.6, 54.9, 52.2, 38.3, 31.2, 19.0, 17.9. 
HRMS (ESI-TOF) calculated for C24H28N2NaO4 [M+Na]+ m/z 431.1941, found 431.1942. 
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H
N
OMe
O
N
H
MeOOC
Ph
3t 
(S)-Methyl 3-methyl-2-((S)-3-phenyl-2-(4-vinylbenzamido)propanamido)butanoate (3t) (related to 
Figure 2): Eluent: hexane/ethyl acetate 2:1,. Yield: 315.5 mg (83%). White solid. 1H NMR 
(CDCl3, 400 MHz) δ 7.74 (d, J = 6.87 Hz, 2H), 7.40 (d, J = 7.79 Hz, 2H), 7.34 (d, J = 8.24 Hz, 
1H), 7.21 (d, J = 7.33 Hz, 1H), 7.14-7.05 (m, 5H), 6.71 (dd, J1 = 17.63 Hz, J1 = 10.99 Hz, 1H), 
5.81 (d, J = 17.86 Hz, 1H), 5.34 (d, J = 10.99 Hz, 1H), 4.86-4.79 (m, 2H), 3.68 (s, 3H), 3.13-2.97 
(m, 2H), 1.45 (d, J = 6.87 Hz, 3H). 13C NMR (CDCl3, 100 MHz) δ 172.4, 171.8, 166.7, 140.8, 
135.92, 135.86, 132.7, 129.2, 128.5, 127.6, 127.0, 126.2, 116.1, 53.6, 52.4, 49.0, 37.8, 18.5. 
HRMS (ESI-TOF) calculated for C22H24N2NaO4 [M+Na]+ m/z 403.1628, found 403.1629. 
 3u 
Buta-1,3-dienylbenzene (3u) (related to Figure 2) (Lishchynskyi et al., 2012): Eluent: pentane. 
Yield: 93.7 mg (72%). Colorless liquid. 1H NMR (CDCl3, 300 MHz) δ 7.67-7.24 (m, 5H), 
7.17-6.22 (m, 3H), 5.61-5.23 (m, 2H). 13C NMR (CDCl3, 75 MHz) δ 137.5, 137.3, 137.2, 133.3, 
133.0, 130.9, 130.5, 129.7, 129.1, 128.7, 128.4, 127.8, 127.2, 126.6, 119.8, 117.8. EI-MS: M+ m/z 
130. 
Me  3v 
1-(Buta-1,3-dienyl)-4-methylbenzene (3v) (related to Figure 2) (Lishchynskyi et al., 2012): Eluent: 
pentane. Yield: 110.9 mg (77%) E/Z 38:62. Colorless liquid. 1H NMR (CDCl3, 400 MHz) δ 
7.30-7.20 (m, 2H), 7.15-6.10 (m, 2H), 6.91-6.70 (m, 1H), 6.54-6.18 (m, 2H), 5.36-5.12 (m, 2H), 
2.34-2.32 (s, 3H). 13C NMR (CDCl3, 100 MHz) δ 137.6, 137.5, 137.0, 134.6, 134.5, 133.5, 133.0, 
130.5, 130.3, 129.5, 129.1, 128.8, 126.5, 119.3, 117.1, 21.4, 21.3. EI-MS: M+ m/z 144. 
Cl  3w 
1-(Buta-1,3-dienyl)-4-chlorobenzene (3w) (related to Figure 2) (Lishchynskyi et al., 2012): Eluent: 
pentane. Yield: 116.5 mg (71%) E/Z 30:70. Colorless liquid. 1H NMR (CDCl3, 400 MHz) δ 
7.32-7.22 (m, 4H), 6.85-6.70 (m, 1H), 6.52-6.23 (m, 2H), 5.41-5.18 (m, 2H). 13C NMR (CDCl3, 
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100 MHz) δ 137.0, 135.9, 135.7, 133.3, 132.92, 132.86, 131.6, 131.4, 130.4, 130.3, 129.2, 128.9, 
128.5, 127.7, 120.4, 118.4. EI-MS: M+ m/z 164. 
Br  3x 
1-Bromo-4-(buta-1,3-dienyl)benzene (3x) (related to Figure 2) (Mundal et al., 2009): Eluent: 
pentane. Yield: 181.0 mg (87%) E/Z 50:50. Colorless liquid. 1H NMR (CDCl3, 400 MHz) δ 
7.45-7.7.40 (m, 2H), 7.25-7.15 (m, 2H), 6.84-6.72 (m, 1H), 6.52-6.43 (m, 1H), 6.37-6.23 (m, 1H), 
5.41-5.19 (m, 2H). 13C NMR (CDCl3, 100 MHz) δ 137.0, 136.3, 136.2, 132.8, 131.8, 131.6, 131.5, 
131.48, 130.7, 130.4, 129.2, 128.0, 121.5, 121.1, 120.5, 118.5. EI-MS: M+ m/z 208. 
 3y 
1-(Buta-1,3-dienyl)-3-nitrobenzene (3y) (related to Figure 2): Eluent: pentane. Yield: 112.6 mg 
(70%). Yellow liquid. 1H NMR (CDCl3, 400 MHz) δ 8.24 (s, 1H), 8.07 (d, J = 8.24 Hz, 1H), 7.69 
(d, J = 7.79 Hz, 1H), 7.48 (t, J = 7.79 Hz, 1H), 6.93-6.87 (m, 1H), 6.62-6.48 (m, 2H), 5.45 (d, J = 
16.94 Hz, 1H), 5.30 (d, J = 10.07 Hz, 1H). 13C NMR (CDCl3, 100 MHz) δ 148.8, 139.1, 136.4, 
132.6, 132.3, 130.3, 129.6, 122.2, 121.0, 120.2. EI-MS: M+ m/z 175. 
 
O
H
N
3z 
N-Phenylacrylamide (3z) (related to Figure 2) (Eriksson et al., 2007): Eluent: hexane/ethyl acetate 
5:1. Yield: 104.4 mg (71%). White solid, mp. 103-104 ℃. 1H NMR (CDCl3, 400 MHz) δ 8.04 (s, 
1H), 7.60 (d, J = 7.33 Hz, 2H), 7.30 (t, J = 7.79 Hz, 2H), 7.11 (t, J = 7.33 Hz, 1H), 6.44- 6.26 (m, 
2H), 5.72 (d, J = 9.62 Hz, 1H). 13C NMR (CDCl3, 100 MHz) δ 164.0, 137.9, 131.4, 129.1, 127.8, 
124.6, 120.3. EI-MS: M+ m/z 147. 
O
H
N
Me 3aa 
N-p-Tolylacrylamide (3aa) (related to Figure 2) (Eriksson et al., 2007): Eluent: hexane/ethyl 
acetate 5:1. Yield: 109.5 mg (68%). White solid, mp. 140-141 ℃. 1H NMR (CDCl3, 400 MHz) δ 
7.71 (s, 1H), 7.47 (d, J = 8.24 Hz, 2H), 7.11 (d, J = 8.24 Hz, 2H), 6.40 (d, J = 16.94 Hz, 1H), 6.26 
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(dd, J 1= 16.72 Hz, J 1= 10.07 Hz, 1H), 5.71 (d, J = 10.07 Hz, 1H), 2.31 (s, 3H). 13C NMR (CDCl3, 
100 MHz) δ 163.7, 135.4, 134.3, 131.4, 129.6, 127.6, 120.3, 21.0. EI-MS: M+ m/z 162. 
O
H
N
3ab 
N-(Naphthalen-2-yl)acrylamide (3ab) (related to Figure 2) (Eriksson et al., 2007): Eluent: 
hexane/ethyl acetate 5:1. Yield: 132.1 mg (67%). White solid, mp. 174-175 ℃. 1H NMR (CDCl3, 
400 MHz) δ 8.29 (s, 1H), 8.16 (s, 1H), 7.76-7.71 (m, 3H), 7.53 (d, J = 8.70 Hz, 1H), 7.44-7.38 (m, 
2H), 6.47 (d, J = 16.94 Hz, 1H), 6.34 (dd, J 1= 16.94 Hz, J 1= 10.07 Hz, 1H), 5.73 (d, J = 10.07 Hz, 
1H). 13C NMR (CDCl3, 100 MHz) δ 164.2, 135.4, 133.9, 131.3, 130.9, 128.8, 128.0, 127.8, 127.6, 
126.6, 125.2, 120.2, 117.3. ESI-MS: [m+H]+ m/z 198. 
O
H
N
MeO 3ac 
N-(4-Methoxyphenyl)acrylamide (3ac) (related to Figure 2) (Eriksson et al., 2007): Eluent: 
hexane/ethyl acetate 5:1. Yield: 132.1 mg (67%). White solid, mp. 97-98 ℃. 1H NMR (CDCl3, 
400 MHz) δ 8.06 (s, 1H), 7.48 (d, J = 8.70 Hz, 2H), 6.80 (d, J = 8.70 Hz, 2H), 6.38 (d, J = 16.94 
Hz, 1H), 6.26 (dd, J 1= 16.94 Hz, J 1= 10.07 Hz, 1H), 5.67 (d, J = 9.62 Hz, 1H), 3.76 (s, 3H). 13C 
NMR (CDCl3, 100 MHz) δ 163.8, 156.6, 131.4, 131.1, 127.4, 122.1, 114.2, 55.6. ESI-MS: [m+H]+ 
m/z 178. 
CF3
4a 
(3,3,3-Trifluoroprop-1-enyl)benzene (4a) (related to Figure 3) (Kathiravan et al., 2015): Eluent: 
pentane, the solvent was removed at 0 ℃ under reduced pressure. Yield: 153.1 mg (89%) with 2c 
as the reactant, 156.6 mg (91%) with 2d as the reactant, E/Z = 6:4. Colorless oil. 1H NMR (CDCl3, 
400 MHz) δ 7.44-7.31 (m, 5H), 7.14 (d, J = 16.49 Hz, 0.4H), 6.90 (d, J = 12.82 Hz, 0.6H), 
6.23-6.14 (m, 0.4H), 5.79-5.69 (m, 0.6H). 19F (CDCl3, 376.5 MHz) δ -57.4, -61.2. 13C NMR 
(CDCl3, 100 MHz) δ 139.8 (JF-C = 5.75 Hz), 137.8 (JF-C = 6.71 Hz), 133.8, 133.5, 130.1, 129.2, 
129.1, 129.07, 128.5, 127.7, 125.1, 124.3, 122.5, 121.6, 118.1 (JF-C = 34.50 Hz), 116.0 (JF-C = 
33.55 Hz). EI-MS: M+ m/z 172. 
Me
CF3
4b 
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(3,3,3-Trifluoroprop-1-enyl)benzene (4b) (related to Figure 3) (Kathiravan et al., 2015): Eluent: 
pentane, the solvent was removed at 0 ℃ under reduced pressure. Yield: 161.9 mg (87%) with 2c 
as the reactant, 169.3 mg (91%) with 2d as the reactant, E/Z = 7:3. Colorless oil. 1H NMR (CDCl3, 
400 MHz) δ 7.53-7.50 (m, 2H), 7.39-7.35 (m, 2H), 7.30 (d, J = 16.03 Hz, 0.3H), 7.05 (d, J = 12.82 
Hz, 0.7H), 6.38-6.29 (m, 0.3H), 6.93-5.83 (m, 0.7H), 2.55 (S, 3H). 19F (CDCl3, 376.5 MHz) δ 
-57.4, -63.0. 13C NMR (CDCl3, 100 MHz) δ 140.5, 139.8 (JF-C = 5.75 Hz), 139.4, 137.7 (JF-C = 
6.71 Hz), 130.9, 130.8, 129.8, 129.2, 127.6, 125.3, 124.5, 122.6, 121.8, 117.1 (JF-C = 34.50 Hz), 
114.9 (JF-C = 33.55 Hz), 21.44, 21.39. EI-MS: M+ m/z 186. 
CF3
4c 
1-(3,3,3-Trifluoroprop-1-enyl)naphthalene (4c) (related to Figure 3) (Kathiravan et al., 2015): 
Eluent: pentane. Yield: 197.6 mg (89%) with 2c as the reactant, 202.1 mg (91%) with 2d as the 
reactant. Colorless oil. 1H NMR (CDCl3, 400 MHz) δ 8.09 (d, J = 8.70 Hz, 1H), 8.00 (d, J = 16.03 
Hz, 1H), 7.93 (d, J = 8.24 Hz, 2H), 7.66-7.58 (m, 3H), 7.51 (t, J = 7.79 Hz, 1H), 6.37-6.28 (m, 
1H). 19F (CDCl3, 376.5 MHz) δ -63.1. 13C NMR (CDCl3, 100 MHz) δ 135.3 (JF-C = 6.71 Hz), 
133.7, 131.2, 131.1, 130.3, 128.9, 127.0, 126.4, 125.5, 124.9, 123.3, 118.9 (JF-C = 33.55 Hz), 
21.44, 21.39. EI-MS: M+ m/z 222. 
CF3MeO
OMe 4d 
1,3-Dimethoxy-5-(3,3,3-trifluoroprop-1-enyl)benzene (4d) (related to Figure 3) (Parsons et al., 
2012): Eluent: pentane. Yield: 201.9 mg (87%) with 2c as the reactant, 211.2 mg (91%) with 2d as 
the reactant, E/Z = 57:43. Colorless oil. 1H NMR (CDCl3, 400 MHz) δ 7.09 (d, J = 16.03 Hz, 
0.43H), 6.87 (d, J = 12.82 Hz, 0.57H), 6.60-6.57 (s, 2H), 6.50-6.48 (s, 1H), 6.24-6.15 (m, 0.43H), 
5.82-5.72 (m, 0.57H), 3.81-3.80 (s, 6H). 19F (CDCl3, 376.5 MHz) δ -57.1, -63.2. 13C NMR (CDCl3, 
100 MHz) δ 161.2, 160.7, 139.8 (JF-C = 5.75 Hz), 137.9 (JF-C = 6.71 Hz), 135.5, 135.4, 125.1, 
124.2, 122.4, 121.5, 118.43 (JF-C = 34.50 Hz), 116.4 (JF-C = 33.55 Hz), 107.0, 105.6, 102.2, 101.4, 
55.43, 55.4. EI-MS: M+ m/z 232. 
CF3
Br 4e 
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1-Bromo-2-(3,3,3-trifluoroprop-1-enyl)benzene (4e) (related to Figure 3) (Hafner et al., 2011): 
Eluent: pentane. Yield: 177.6 mg (71%) with 2c as the reactant, E/Z = 54:46. Colorless oil. 1H 
NMR (CDCl3, 400 MHz) δ 7.61-7.50 (m, 2H), 7.39-7.17 (m, 2.55H), 7.00 (d, J = 12.36 Hz, 
0.57H), 6.19-6.10 (s, 0.54H), 5.92-5.82 (m, 0.46H). 19F (CDCl3, 376.5 MHz) δ -57.7, -63.5. 13C 
NMR (CDCl3, 100 MHz) δ 138.8 (JF-C = 5.75 Hz), 136.7 (JF-C = 6.71 Hz), 134.7, 133.7, 133.5, 
132.5, 131.2, 130.5, 130.4, 130.36, 128.0, 127.7, 127.3, 124.8, 124.6, 124.0, 123.1, 122.0, 121.3, 
120.0 (JF-C = 34.50 Hz), 118.7 (JF-C = 33.55 Hz). EI-MS: M+ m/z 250. 
CF3Br
4f 
1-Bromo-3-(3,3,3-trifluoroprop-1-enyl)benzene (4f) (related to Figure 3) (Abdukader et al., 2011): 
Eluent: pentane. Yield: 222.6 mg (89%) with 2c as the reactant, 222.5 mg (89%) with 2d as the 
reactant, E/Z = 75:25. Colorless oil. 1H NMR (CDCl3, 400 MHz) δ 7.59 (s, 0.25H), 7.50-7.47 (m, 
1.75H), 7.37-7.31 (m, 1H), 7.27-7.21 (m, 1H), 7.07 (d, J = 16.03 Hz, 0.25H), 6.86 (d, J = 12.36 Hz, 
0.75H), 6.24-6.16 (m, 0.25H), 5.86-5.76 (m, 0.75H). 19F (CDCl3, 376.5 MHz) δ -57.4, -63.2. 13C 
NMR (CDCl3, 100 MHz) δ 138.1, 136.3, 135.7, 135.5, 133.0, 132.0, 131.8, 130.5, 130.4, 129.9, 
127.4, 126.6, 126.3, 123.9, 123.1, 122.4, 122.0, 121.2, 119.6 (JF-C = 34.50 Hz), 117.4 (JF-C = 33.55 
Hz). EI-MS: M+ m/z 250. 
Br
CF3
4g 
1-Bromo-4-(3,3,3-trifluoroprop-1-enyl)benzene (4g) (related to Figure 3) (Kathiravan et al., 2015): 
Eluent: Pentane. Yield: 220 mg (88%) with 2c as the reactant, 230.1 mg (92%) with 2d as the 
reactant, E/Z = 66:34. Colorless oil. 1H NMR (CDCl3, 400 MHz) δ 7.52-7.47 (m, 2H), 7.31-7.24 
(m, 2H), 7.01 (d, J = 16.03 Hz, 0.34H), 6.84 (d, J = 12.82 Hz, 0.66H), 6.23-6.14 (m, 0.34H), 
5.84-5.74 (m, 0.66H). 19F (CDCl3, 376.5 MHz) δ -57.5, -63.3. 13C NMR (CDCl3, 100 MHz) δ 
138.6 (JF-C = 5.75 Hz), 136.6 (JF-C = 6.71 Hz), 132.6, 132.4, 132.3, 131.7, 130.63. 130.61, 129.1, 
124.4, 124.1, 123.5, 121.4. 118.9 (JF-C = 35.46 Hz), 116.6 (JF-C = 34.50 Hz). EI-MS: M+ m/z 250. 
CF3
CN
4h 
2-(3,3,3-Trifluoroprop-1-enyl)benzonitrile (4h) (related to Figure 3) (Kathiravan et al., 2015): 
Eluent: pentane/CH2Cl2 5:1. Yield: 159.6 mg (81%) with 2c as the reactant, 171.4 mg (87%) with 
-S155 - 
2d as the reactant, E/Z = 71:29. Colorless oil. 1H NMR (CDCl3, 400 MHz) δ 7.69-7.13 (m, 5H), 
6.46-5.97 (m, 1H). 19F (CDCl3, 376.5 MHz) δ -58.0, -63.9. 13C NMR (CDCl3, 100 MHz) δ 137.3, 
136.1, 135.5 (JF-C = 4.79 Hz), 133.4, 133.2, 132.6, 132.5, 130.1, 129.33, 129.30, 129.2, 126.8, 
125.6, 122.3 (JF-C = 34.50 Hz), 120.8, 120.4 (JF-C = 34.50 Hz), 117.0, 116.9, 112.4, 112.0. EI-MS: 
M+ m/z 197. 
NC
CF3
4i 
4-(3,3,3-Trifluoroprop-1-enyl)benzonitrile (4i) (related to Figure 3) (Kathiravan et al., 2015): 
Eluent: pentane/CH2Cl2 5:1. Yield: 165.5 mg (84%) with 2c as the reactant, 177.4 mg (90%) with 
2d as the reactant, E/Z = 71:29. Colorless oil. 1H NMR (CDCl3, 400 MHz) δ 7.69-7.63 (m, 5H), 
7.56-7.45 (m, 2H), 7.15 (d, J = 16.03 Hz, 0.29H), 6.96 (d, J = 12.36 Hz, 0.71H), 6.36-6.27 (m, 
0.29H), 5.97-5.87 (m, 0.71H). 19F (CDCl3, 376.5 MHz) δ -57.6, -63.7. 13C NMR (CDCl3, 100 
MHz) δ 138.3, 137.7 (JF-C = 5.75 Hz), 136.0 (JF-C = 6.71 Hz), 132.8, 132.1, 129.4, 128.1, 123.7, 
121.7, 121.0, 121.95 (JF-C = 34.50 Hz), 119.4 (JF-C = 34.50 Hz), 18.5, 118.3, 113.5, 112.6. EI-MS: 
M+ m/z 197. 
CF3F3C
4j 
1,3-Bis(3,3,3-trifluoroprop-1-enyl)benzene (4j) (related to Figure 3) (Prakash et al., 2015): Eluent: 
pentane. Yield: 215.5 mg (81%) with 2c as the reactant, E/Z = 60:40. Colorless oil. 1H NMR 
(CDCl3, 400 MHz) δ 7.50-7.38 (m, 4H), 7.16-7.12 (m, 0.8H), 6.95-6.90 (m, 1.2H), 6.29-6.17 (m, 
0.8H), 5.88-5.76 (m, 1.2H). 19F (CDCl3, 376.5 MHz) δ -57.4, -57.6, -63.4, -63.5. 13C NMR 
(CDCl3, 100 MHz) δ 139.1 (JF-C = 5.75 Hz), 138.9(JF-C = 5.75 Hz), 137.2 (JF-C = 6.71 Hz), 137.0 
(JF-C = 6.71 Hz), 134.7, 134.4, 134.0, 133.7, 130.4, 129.8, 129.5, 129.2, 129.0, 128.6, 128.0, 126.9, 
125.0, 124.9, 124.2, 122.3, 122.3, 121.5, 119.4 (JF-C = 34.50 Hz), 119.0 (JF-C = 34.50 Hz), 116.8 
(JF-C = 34.50 Hz). EI-MS: M+ m/z 266. 
CF3
F3C 4k 
1,4-Bis(3,3,3-trifluoroprop-1-enyl)benzene (4k) (related to Figure 3) (Satoru et al., 2015): Eluent: 
pentane. Yield: 236.8 mg (89%) with 2c as the reactant, 144.7 mg (92%) with 2d as the reactant, 
E/Z = 60:40. Colorless oil. 1H NMR (CDCl3, 400 MHz) δ 7.48-7.38 (m, 4H), 7.19-7.13 (m, 
-S156 - 
1.26H), 6.95-6.91 (m, 0.74H), 6.31-6.22 (m, 1.26H), 5.88-5.78 (m, 0.74H). 19F (CDCl3, 376.5 
MHz) δ -51.7, -57.6, -63.5, -69.4. 13C NMR (CDCl3, 100 MHz) δ 139.0 (JF-C = 5.75 Hz), 138.8 
(JF-C = 5.75 Hz), 136.9 (JF-C = 6.71 Hz), 136.8 (JF-C = 6.71 Hz), 135.4, 135.1, 134.4, 134.1, 129.7, 
129.1, 128.2, 127.6, 125.0, 124.3, 122.3, 121.6, 119.6 (JF-C = 34.50 Hz), 118.9 (JF-C = 34.50 Hz), 
117.0 (JF-C = 34.50 Hz), 116.9 (JF-C = 34.50 Hz). EI-MS: M+ m/z 266. 
H
N CF3
O OH 4l 
4,4,4-Trifluoro-3-hydroxy-N-phenylbutanamide (4l) (related to Figure 3): Eluent: hexane/ethyl 
acetate 5:1. Yield: 216.7 mg (93%) with 2c as the reactant. White solid, mp. 74-75 ℃. 1H NMR 
(DMSO, 400 MHz) δ 10.1 (s, 1H), 7.62 (d, J = 7.33 Hz, 2H), 7.31 (t, J = 7.33 Hz, 2H), 7.05 (t, J = 
7.79 Hz, 1H), 6.55 (d, J = 6.41 Hz, 1H), 4.49-4.41 (m, 1H), 2.70-2.59 (m, 2H). 19F (DMSO, 376.5 
MHz) δ -78.1. 13C NMR (DMSO, 100 MHz) δ 167.1, 139.1, 128.8, 125.8 (JF-C = 282.75 Hz), 
123.4, 119.1, 66.1 (JF-C = 30.67 Hz), 37.8. HRMS (ESI-TOF) calculated for C10H9F3NO2 [M-H]- 
m/z 232.0591, found 232.0589. 
H
N CF3
O
Me
OH
4m 
4,4,4-Trifluoro-3-hydroxy-N-p-tolylbutanamide (4m) (related to Figure 3): Eluent: hexane/ethyl 
acetate 5:1. Yield: 234.7 mg (95%) with 2c as the reactant. White solid, mp. 103-104 ℃. 1H NMR 
(DMSO, 400 MHz) δ 10.0 (s, 1H), 7.51 (d, J = 8.70 Hz, 2H), 7.12 (t, J = 8.70 Hz, 2H), 6.54 (d, J 
= 6.41 Hz, 1H), 4.51-4.41 (m, 1H), 2.69-2.58 (m, 2H), 2.26 (s, 3H). 19F (DMSO, 376.5 MHz) δ 
-78.1. 13C NMR (DMSO, 100 MHz) δ 166.8, 136.6, 132.2, 129.2, 125.8 (JF-C = 281.79 Hz), 119.1, 
66.1 (JF-C = 30.67 Hz), 37.7, 20.5. HRMS (ESI-TOF) calculated for C11H11F3NO2 [M-H]- m/z 
246.0747, found 246.0746. 
H
N CF3
O OH 4n 
4,4,4-Trifluoro-3-hydroxy-N-(naphthalen-2-yl)butanamide (4n) (related to Figure 3): Eluent: 
hexane/ethyl acetate 5:1. Yield: 254.8 mg (90%) with 2c as the reactant. Light yellow solid, mp. 
167-168 ℃. 1H NMR (DMSO, 400 MHz) δ 10.3 (s, 1H), 8.35 (s, 1H), 7.88-7.81 (m, 3H), 7.61 (d, 
J = 8.70 Hz, 1H), 7.47 (t, J = 7.33 Hz, 1H), 7.40 (t, J = 7.79 Hz, 1H), 6.60 (d, J = 6.41 Hz, 1H), 
4.57-4.47 (m, 1H), 2.78-2.68 (m, 2H). 19F (DMSO, 376.5 MHz) δ -78.0. 13C NMR (DMSO, 100 
-S157 - 
MHz) δ 167.9, 137.1, 133.9, 130.3, 128.9, 128.0, 127.8, 127.0, 126.3 (JF-C = 283.71 Hz), 125.2, 
120.4, 115.7, 66.7 (JF-C = 30.67 Hz), 38.4. HRMS (ESI-TOF) calculated for C14H11F3NO2 [M-H]- 
m/z 282.0747, found 282.0742. 
H
N CF3
O
MeO
OH
4o 
4,4,4-Trifluoro-3-hydroxy-N-(naphthalen-2-yl)butanamide (4o) (related to Figure 3): Eluent: 
hexane/ethyl acetate 5:1. Yield: 249.9 mg (95%) with 2c as the reactant. White solid, mp. 
59-60 ℃. 1H NMR (DMSO, 400 MHz) δ 9.97 (s, 1H), 7.51 (d, J = 8.70 Hz, 2H), 6.88 (d, J = 8.70 
Hz, 2H), 6.51 (d, J = 6.41 Hz, 1H), 4.47-4.40 (m, 1H), 3.71 (s, 3H), 2.65-2.54 (m, 2H). 19F 
(DMSO, 376.5 MHz) δ -78.1. 13C NMR (DMSO, 100 MHz) δ 167.0, 155.8, 132.7, 126.3 (JF-C = 
281.79 Hz), 121.1, 114.4, 66.6 (JF-C = 30.67 Hz), 55.6, 38.1. HRMS (ESI-TOF) calculated for 
C11H11F3NO3 [M-H]- m/z 262.0697, found 262.0698. 
 
5a 
(E)-1,2-Diphenylethene (5a) (related to Figure 4) (McNulty et al., 2009): Eluent: hexane. Yield: 
163.9 mg (91%). Colorless oil. 1H NMR (CDCl3, 400 MHz) δ 7.23-7.15 (m, 10H), 6.59 (s, 2H). 
13C NMR (CDCl3, 100 MHz) δ 137.4, 130.4, 129.0, 128.3, 127.2. EI-MS: M+ m/z 180. 
Me
5b 
(E)-1,2-Diphenylethene (5b) (related to Figure 4)  (Huo et al., 2009): Eluent: hexane. Yield: 
174.6 mg (90%). Colorless oil. 1H NMR (CDCl3, 400 MHz) δ 7.26-7.12 (m, 7H), 7.00 (d, J = 7.79 
Hz, 2H), 6.54 (s, 2H), 2.29 (s, 3H). 13C NMR (CDCl3, 100 MHz) δ 137.6, 137.0, 134.4, 130.3, 
129.7, 129.0, 128.97, 128.9, 128.3, 127.1, 21.3. EI-MS: M+ m/z 194. 
OMe5c 
(E)-1-Methoxy-2-styrylbenzene (5c) (related to Figure 4) (McNulty et al., 2009): Eluent: hexane. 
Yield: 187.0 mg (89%). Colorless oil. 1H NMR (CDCl3, 400 MHz) δ 7.23-7.11 (m, 7H), 6.85 (d, J 
= 8.24 Hz, 1H), 6.74-6.67 (m, 2H), 6.61 (d, J = 11.91 Hz, 1H), 3.77 (s, 3H). 13C NMR (CDCl3, 
-S158 - 
100 MHz) δ 157.3, 137.4, 130.3, 130.1, 128.9, 128.7, 128.1, 127.0, 126.3, 125.9, 120.3, 110.7, 
55.5. EI-MS: M+ m/z 210. 
OMe
5d 
(E)-1-Methoxy-3-styrylbenzene (5d) (related to Figure 4) (Roberts et al., 2004): Eluent: hexane. 
Yield: 191.2 mg (91%). Colorless oil. 1H NMR (CDCl3, 400 MHz) δ 7.27-7.10 (m, 6H), 6.84-6.72 
(m, 3H), 6.63-6.53 (m, 2H), 3.63 (s, 3H). 13C NMR (CDCl3, 100 MHz) δ 159.5, 138.7, 137.4, 
130.6, 130.3, 129.3, 129.0, 128.3, 127.3, 121.6, 113.9, 113.4, 55.1. EI-MS: M+ m/z 210. 
OMe
5e 
(E)-1-Methoxy-4-styrylbenzene (5e) (related to Figure 4) (McNulty et al., 2009): Eluent: hexane. 
Yield: 195.4 mg (93%). Colorless solid, mp. 136-137 ℃. 1H NMR (CDCl3, 400 MHz) δ 
7.28-7.16 (m, 7H), 6.74 (d, J = 8.60 Hz, 2H), 6.51 (s, 2H), 3.77 (s, 3H). 13C NMR (CDCl3, 100 
MHz) δ 158.8, 137.7, 130.3, 129.9, 128.94, 128.88, 128.4, 127.0, 113.7, 55.3. EI-MS: M+ m/z 
210. 
OMe
OMe
5f 
(E)-1,3-Dimethoxy-5-styrylbenzene (5f) (related to Figure 4) (Roberts et al., 2004): Eluent: 
hexane. Yield: 220.9 mg (92%). Colorless solid, 129-130 ℃. 1H NMR (CDCl3, 400 MHz) δ 
7.27-7.14 (m, 5H), 6.60 (d, J = 12.36 Hz, 1H), 6.51 (d, J = 11.91 Hz, 1H), 6.39 (s, 2H), 6.31 (s, 
1H), 3.60 (s, 6H). 13C NMR (CDCl3, 100 MHz) δ 160.6, 139.1, 137.3, 130.8, 130.3, 129.0, 128.3, 
127.3, 106.8, 100.0, 55.2. EI-MS: M+ m/z 240. 
O
Ph
5g 
(E)-1-(Benzyloxy)-4-styrylbenzene (5g) (related to Figure 4) (Richmond et al., 2015): Eluent: 
hexane. Yield: 266.0 mg (93%). Colorless solid, 32-33 ℃. 1H NMR (CDCl3, 400 MHz) δ 
7.41-7.16 (m, 12H), 6.82 (d, J = 8.70 Hz, 2H), 6.51 (s, 2H), 5.02 (s, 2H). 13C NMR (CDCl3, 100 
MHz) δ 158.0, 137.7, 137.1, 130.3, 130.0, 129.9, 128.9, 128.7, 128.4, 128.1, 127.6, 127.0, 114.6, 
70.1. EI-MS: M+ m/z 286. 
-S159 - 
Cl 5h 
(E)-1-Chloro-2-styrylbenzene (5h) (related to Figure 4) (Heynekamp et al., 2006): Eluent: hexane. 
Yield: 190.5 mg (89%). Colorless oil. 1H NMR (CDCl3, 400 MHz) δ 7.38 (d, J = 7.79 Hz, 1H), 
7.20-7.11 (m, 7H), 7.01 (t, J = 7.79 Hz, 1H), 6.72-6.65 (m, 2H). 13C NMR (CDCl3, 100 MHz) δ 
136.5, 136.1, 133.8, 131.8, 130.8, 129.6, 129.1, 128.6, 128.3, 127.5, 127.4, 126.5. EI-MS: M+ m/z 
214. 
Cl
5i 
(E)-1-Chloro-4-styrylbenzene (5i) (related to Figure 4) (McNulty et al., 2009): Eluent: hexane. 
Yield: 199.0 mg (93%). Colorless oil. 1H NMR (CDCl3, 400 MHz) δ 7.26-7.13 (m, 9H), 7.20-7.11 
(m, 7H), 6.62 (d, J = 12.04 Hz, 1H), 6.51 (d, J = 12.04 Hz, 1H). 13C NMR (CDCl3, 100 MHz) δ 
137.0, 135.8, 132.9, 131.1, 130.3, 129.0, 128.9, 128.53, 128.47, 127.4. EI-MS: M+ m/z 214. 
Br
5j 
(E)-1-Bromo-4-styrylbenzene (5j) (related to Figure 4) (McNulty et al., 2009): Eluent: hexane. 
Yield: 234.8 mg (91%). Colorless oil. 1H NMR (CDCl3, 400 MHz) δ 7.33 (d, J = 7.57 Hz, 2H), 
7.25-7.17 (m, 5H), 7.09 (d, J = 7.57 Hz, 2H), 6.62 (d, J = 11.70 Hz, 1H), 6.49 (d, J = 12.38 Hz, 
1H). 13C NMR (CDCl3, 100 MHz) δ 136.9, 136.2, 131.5, 131.1, 130.7, 129.1, 128.9, 128.5, 127.5, 
121.1. EI-MS: M+ m/z 258. 
Br
Me
5k 
(E)-2-Bromo-4-methyl-1-styrylbenzene (5k) (related to Figure 4) (McNulty et al., 2009): Eluent: 
hexane. Yield: 244.9 mg (90%). Colorless oil. 1H NMR (CDCl3, 300 MHz) δ 7.40 (s, 1H), 7.14 (s, 
5H), 7.04 (d, J = 7.79 Hz, 1H), 6.85 (d, J = 7.79 Hz, 1H), 6.62 (d, J = 11.91 Hz, 1H), 6.57(d, J = 
12.36 Hz, 1H), 2.26 (s, 3H). 13C NMR (CDCl3, 75 MHz) δ 139.0, 136.6, 134.9, 133.2, 131.1, 
130.6, 129.5, 129.1, 128.2, 128.0, 127.3, 123.8, 20.9 EI-MS: M+ m/z 272. 
Br
OMe
5l 
-S160 - 
(E)-2-Bromo-4-methoxy-1-styrylbenzene (5l) (related to Figure 4) (McNulty et al., 2009): Eluent: 
hexane. Yield: 265.0 mg (92%). Colorless oil. 1H NMR (CDCl3, 300 MHz) δ 7.23-7.05 (m, 7H), 
6.65-6.53 (m, 3H), 3.76 (s, 3H). 13C NMR (CDCl3, 75 MHz) δ 159.3, 136.8, 131.4, 130.7, 130.1, 
129.1, 129.07, 128.3, 127.3, 124.4. 117.6, 113.6, 55.6. HRMS (ESI-TOF) calculated for 
C15H11BrF [M+H]+ m/z 289.0228, found 289.0230. 
Br
F
5m 
(E)-1-Bromo-4-fluoro-2-styrylbenzene (5m) (related to Figure 4): Eluent: hexane. Yield: 240.2 
mg (87%). Colorless oil. 1H NMR (CDCl3, 400 MHz) δ 7.53-7.50 (m, 1H), 7.21-7.12 (m, 5H), 
6.88 (d, J = 9.16 Hz, 1H), 6.79 (t, J = 8.24 Hz, 1H), 6.71 (d, J = 11.91 Hz, 1H), 6.54 (d, J = 12.36 
Hz, 1H). 19F (CDCl3, 376.5 MHz) δ -114.8. 13C NMR (CDCl3, 100 MHz) δ 162.9 (JF-C = 247.28 
Hz), 139.8 (JF-C = 7.67 Hz), 135.9, 134.0 (JF-C = 8.63 Hz), 132.5, 129.0, 128.52, 128.47, 127.8, 
118.3, 117.8, 117.6, 116.2, 116.0. HRMS (ESI-TOF) calculated for C14H14BrF [M+H]+ m/z 
277.0028, found 277.0026. 
Br
F
5n 
(E)-2-Bromo-4-fluoro-1-styrylbenzene (5n) (related to Figure 4): Eluent: hexane. Yield: 240.1 mg 
(87%). Colorless oil. 1H NMR (CDCl3, 400 MHz) δ 7.32 (d, J = 8.24 Hz, 1H), 7.24-7.09 (m, 6H), 
6.77 (d, J = 8.24 Hz, 1H), 6.66 (d, J = 12.36 Hz, 1H), 6.53 (d, J = 11.91 Hz, 1H). 19F (CDCl3, 
376.5 MHz) δ -112.4. 13C NMR (CDCl3, 100 MHz) δ 161.5 (JF-C = 251.1 Hz), 136.2, 134.1(JF-C = 
3.83 Hz), 131.9, 131.8, 129.0, 128.98, 128.5, 128.4, 128.3, 127.5, 124.1 (JF-C = 9.58 Hz), 119.9 
(JF-C = 24.92 Hz), 114.6 (JF-C = 21.09 Hz). HRMS (ESI-TOF) calculated for C14H14BrF [M+H]+ 
m/z 277.0028, found 277.0031. 
NO2 5o 
(E)-1-Nitro-2-styrylbenzene (5o) (related to Figure 4) (Roberts et al., 2004): Eluent: hexane. Yield: 
189 mg (84%). Yellow solid, mp. 72-73 ℃. 1H NMR (CDCl3, 400 MHz) δ 8.08-8.04 (m, 1H), 
7.37-7.34 (m, 2H), 7.26-7.22 (m, 1H), 7.16-7.13 (m, 3H), 7.06-7.03 (m, 2H), 6.88 (d, J = 11.91 Hz, 
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1H), 6.74 (d, J = 11.91 Hz, 1H). 13C NMR (CDCl3, 100 MHz) δ 148.2, 135.9, 133.7, 133.1, 132.3, 
131.9, 129.2, 129.0, 128.3, 128.2, 127.6, 127.2, 126.5, 124.7. EI-MS: M+ m/z 225. 
NO2
5p 
(E)-1-Nitro-3-styrylbenzene (5p) (related to Figure 4) (Nobuaki et al., 2001): Eluent: hexane. 
Yield: 182.3 mg (81%). Yellow Solid, mp. 106-107 ℃. 1H NMR (CDCl3, 400 MHz) δδ 8.25 (s, 
1H), 8.06 (d, J = 8.24 Hz, 1H), 7.68 (d, J = 7.79 Hz, 1H), 7.49 (t, J = 7.79 Hz, 1H), 6.93-6.86 (m, 
1H), 6.61-6.48 (m, 2H), 5.45 (d, J = 16.94 Hz, 1H), 5.30 (d, J = 10.07 Hz, 1H). 13C NMR (CDCl3, 
100 MHz) δ 148.4, 139.0, 136.2, 135.0, 133.2, 129.2, 129.0, 128.8, 128.7, 128.0, 127.8, 126.9, 
123.9, 122.0. EI-MS: M+ m/z 225. 
NO2
5q 
(E)-1-Nitro-4-styrylbenzene (5q) (related to Figure 4) (McNulty et al., 2009): Eluent: hexane. 
Yield: 184.6 mg (82%). Yellow solid, mp.156-157 ℃. 1H NMR (CDCl3, 400 MHz) δ 8.19 (d, J = 
8.70 Hz, 2H), 7.60 (d, J = 9.16 Hz, 2H), 7.53 (d, J = 7.33 Hz, 2H), 7.39 (t, J = 7.79 Hz, 2H), 7.32 
(t, J = 7.33 Hz, 1H), 7.25 (d, J = 16.94 Hz, 1H), 7.12 (d, J = 16.49 Hz, 1H). 13C NMR (CDCl3, 100 
MHz) δ 146.8, 143.9, 136.3, 133.4, 129.0, 128.9, 127.1, 126.9, 126.3, 124.2. EI-MS: M+ m/z 225. 
N
5r 
(E)-2-Styrylpyridine (5r) (related to Figure 4) (Heynekamp et al., 2004): Eluent: hexane/ethyl 
acetate 5:1. Yield: 153.9 mg (85%). Light yellow oil. 1H NMR (CDCl3, 300 MHz) δ 8.57 (d, J = 
5.04 Hz, 1H), 7.65-7.56 (m, 1H), 7.42-7.34 (m, 2H), 7.30-7.20 (m, 3H), 7.13 (d, J = 10.53 Hz, 1H), 
7.05 (t, J = 6.41 Hz, 1H), 6.82 (d, J = 12.36 Hz, 1H), 6.69 (d, J = 12.36 Hz, 1H). 13C NMR (CDCl3, 
75 MHz) δ 156.4, 149.6, 136.7, 135.6, 133.3, 130.5, 128.9, 128.8, 128.3, 127.6, 127.1, 123.9, 
121.8. ESI-MS: [M+H]+ m/z 182. 
S
5s 
(E)-2-Styrylthiophene (5s) (related to Figure 4) (Yang et al., 2012): Eluent: hexane/ethyl acetate 
50:1. Yield: 153.9 mg (82%). Yellow oil. 1H NMR (CDCl3, 300 MHz) δ 7.37-7.17 (m, 5H), 7.07 
(d, J = 5.16 Hz, 1H), 6.96 (d, J = 3.78 Hz, 1H), 6.87 (t, J = 3.78 Hz, 1H), 6.69 (d, J = 12.04 Hz, 
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1H), 6.57 (d, J = 11.70 Hz, 1H). 13C NMR (CDCl3, 75 MHz) δ 139.9, 137.5, 129.0, 128.95, 128.7, 
128.3, 128.28, 127.6, 127.2, 126.6, 125.7, 123.5. EI-MS: M+ m/z 186. 
B
O
O
5t 
(E)-4,4,5,5-Tetramethyl-2-(4-styrylphenyl)-1,3,2-dioxaborolane (5t) (related to Figure 4) (Li et al., 
2015): Eluent: hexane/ethyl acetate 20:1. Yield: 153.9 mg (82%). White solid, mp. 123-124 ℃. 
1H NMR (CDCl3, 400 MHz) δ 7.67 (d, J = 8.24 Hz, 2H), 7.26-7.15 (m, 7H), 6.96 (d, J = 3.78 Hz, 
1H), 6.63-6.56 (m, 2H), 1.32 (s, 12H). 11B (CDCl3, 102.7 MHz) 29.7. 13C NMR (CDCl3, 100 MHz) 
δ 140.3, 137.1, 134.8, 131.0, 130.3, 129.0, 128.31, 128.27, 127.3, 126.0, 83.8, 25.0. EI-MS: M+ 
m/z 291. 
5u 
(1E,3E)-1,4-Diphenylbuta-1,3-diene (5u) (related to Figure 4) (Huo et al., 2009): Eluent: hexane. 
Yield: 162.8 mg (79%). Colorless oil. 1H NMR (CDCl3, 400 MHz) δ 7.46 (d, J = 7.33 Hz, 4H), 
7.35 (t, J = 7.33 Hz, 4H), 7.24 (t, J = 8.24 Hz, 2H), 7.01-6.93 (m, 2H), 7.72-6.65 (m, 2H). 13C 
NMR (CDCl3, 100 MHz) δ 137.5, 133.0, 129.4, 128.8, 127.7, 126.5. EI-MS: M+ m/z 206. 
5v 
Penta-1,3-dienylbenzene (5v) (related to Figure 4) (Anton et al., 2012): Eluent: pentane. Yield: 
119.6 mg (83%), E/Z = 1:1. Colorless oil. 1H NMR (CDCl3, 400 MHz) δ 7.42-7.16 (m, 5H), 
6.77-5.55 (m, 4H), 1.87-1.78 (m, 3H). 13C NMR (CDCl3, 100 MHz) δ 138.0, 137.8, 137.7, 132.7, 
132.0, 130.6, 130.4, 129.9, 129.7, 129.5, 129.2, 129.04, 129.0, 128.7, 128.66, 128.31, 128.26, 
128.0, 127.5, 127.3, 127.2, 127.0, 126.8, 126.4, 126.2, 125.8, 125.2, 124.3, 18.53, 18.49. EI-MS: 
M+ m/z 144. 
Me
Me 5w 
1-Methyl-4-(prop-1-enyl)benzene (5w) (related to Figure 4) (Monfredini et al., 2012): Eluent: 
pentane. Yield: 104.3 mg (79%), E/Z = 45:55. Colorless oil. 1H NMR (CDCl3, 400 MHz) δ 
7.22-7.07 (m, 4H), 6.41-6.34 (m, 1H), 6.21-6.12 (m, 0.45H), 5.78-5.69 (m, 0.55H), 2.33-2.31 (s, 
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3H), 1.90-1.84 (m, 3H). 13C NMR (CDCl3, 100 MHz) δ 136.5, 136.2, 135.3, 134.9, 131.0, 129.8, 
129.3, 128.9, 128.87, 126.1, 125.8, 124.7, 21.3, 18.6, 14.8. EI-MS: M+ m/z 132. 
Me 5x 
1-Methyl-4-(prop-1-enyl)benzene (5x) (related to Figure 4) (Monfredini et al., 2012): Eluent: 
pentane. Yield: 116.9 mg (80%), E/Z = 31: 69. Colorless oil. 1H NMR (CDCl3, 400 MHz) δ 
7.23-7.07 (m, 4H), 6.35-6.32 (m, 1H), 6.23-6.16 (m, 0.31H), 5.62-5.56 (m, 0.69H), 2.37-2.17 (m, 
5H), 1.09-1.03 (m, 3H). 13C NMR (CDCl3, 100 MHz) δ 136.5, 136.2, 135.3, 135.0, 134.2, 131.7, 
129.3, 128.9, 128.8, 128.2, 125.9, 26.2, 22.1, 21.3, 21.2, 14.6, 13.9. EI-MS: M+ m/z 146. 
Me 5y 
1-Methyl-4-(pent-1-enyl)benzene (5y) (related to Figure 4) (McNulty et al., 2009): Eluent: 
pentane. Yield: 129.7 mg (81%), E/Z = 45:55. Colorless oil. 1H NMR (CDCl3, 400 MHz) δ 
7.24-7.07 (m, 4H), 6.39-6.32 (m, 1H), 6.19-6.12 (m, 0.55H), 5.64-5.58 (m, 0.45H), 2.33-2.13 (m, 
5H), 1.53-1.42 (m, 2H), 0.96-0.91 (m, 3H). 13C NMR (CDCl3, 100 MHz) δ 136.5, 136.2, 135.3, 
135.1, 132.5, 130.0, 129.8, 129.3, 128.9, 128.8, 125.9, 35.2, 30.9, 23.3, 22.7, 21.3, 21.2, 14.0, 13.9. 
EI-MS: M+ m/z 160. 
Me 5z 
1-(Hex-1-enyl)-4-methylbenzene (5z) (related to Figure 4) (Andrews et al., 2013): Eluent: 
pentane. Yield: 142.7 mg (82%), E/Z = 50:50. Colorless oil. 1H NMR (CDCl3, 400 MHz) δ 
7.24-7.06 (m, 4H), 6.38-6.32 (m, 1H), 6.20-6.12 (m, 0.5H), 5.64-5.58 (m, 0. 5H), 2.35-2.16 (m, 
5H), 1.48-1.32 (m, 4H), 0.94-0.87 (m, 3H). 13C NMR (CDCl3, 100 MHz) δ 136.5, 136.1, 135.3, 
135.1, 132.6, 130.3, 129.6, 129.3, 128.9, 128.8, 128.6, 125.9, 32.8, 32.3, 31.7, 28.5, 22.6, 22.4, 
21.2, 14.1. EI-MS: M+ m/z 174. 
Me 5aa 
1-Methyl-4-(oct-1-enyl)benzene (5aa) (related to Figure 4) (Andrews et al., 2013): Eluent: hexane. 
Yield: 176.6 mg (91%), E/Z = 65:35. Colorless oil. 1H NMR (CDCl3, 400 MHz) δ 7.35-7.18 (m, 
10H), 6.58 (d, J = 11.45 Hz, 0.65H), 6.44 (d, J = 16.03 Hz, 0.35H), 6.38-6.31 (m, 0. 35H), 
5.88-5.81 (m, 0.65H), 3.68-3.52 (m, 2H). 13C NMR (CDCl3, 100 MHz) δ 140.9, 140.3, 137.6, 
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137.4, 131.2, 130.8, 130.2, 129.4, 129.0, 128.9, 128.8, 128.68, 128.66, 128.5, 128.42, 128.37, 
127.27, 127.0, 126.3, 126.24, 126.20, 39.5, 34.8. EI-MS: M+ m/z 194. 
Ph
5ab 
Prop-1-ene-1,3-diyldibenzene (5ab) (related to Figure 4) (Andrews et al., 2013): Eluent: hexane. 
Yield: 175.8 mg (91%), E/Z = 32:68. Colorless oil. 1H NMR (CDCl3, 400 MHz) δ 7.22-7.05 (m, 
4H), 6.37-6.30 (m, 1H), 6.18-6.11 (m, 0.32H), 5.63-5.56 (m, 0. 68H), 2.33-2.14 (m, 5H), 
1.48-1.27 (m, 8H), 0.90-0.85 (m, 3H). 13C NMR (CDCl3, 100 MHz) δ 136.5, 136.1, 135.3, 135.1, 
132.6, 130.2, 129.7, 129.3, 128.9, 128.8, 128.7, 125.9, 33.2, 31.9, 30.2, 29.6, 29.2, 29.1, 28.7, 22.8, 
21.2, 14.2. EI-MS: M+ m/z 202. 
Ph
5ac 
But-1-ene-1,4-diyldibenzene (5ac) (related to Figure 4) (Huo et al., 2009): Eluent: hexane. Yield: 
181.0 mg (87%), E/Z = 44:56. Colorless oil. 1H NMR (CDCl3, 400 MHz) δ 7.46-7.32 (m, 10H), 
6.58-6.52 (m, 1H), 6.41-6.34 (m, 0.56H), 5.86-5.79 (m, 0. 44H), 2.90 (q, J = 7.79 Hz, 2H), 2.78 (q, 
J = 7.33 Hz, 1H), 2.65 (q, J = 7.33 Hz, 1H). 13C NMR (CDCl3, 100 MHz) δ 141.9, 141.8, 137.8, 
137.7, 131.9, 130.5, 130.0, 129.5, 129.0, 128.8, 128.6, 128.5, 128.3, 127.1, 126.7, 126.1, 126.03, 
126.0, 36.2, 36.0, 35.0, 30.5. EI-MS: M+ m/z 208. 
5ad 
(2-Cyclohexylvinyl)benzene (5ad) (related to Figure 4) (McMahon et al., 2013): Eluent: hexane. 
Yield: 167.5 mg (90%), E/Z = 75:25. Colorless oil. 1H NMR (CDCl3, 300 MHz) δ 7.35-7.15 (m, 
5H), 6.37-6.29 (m, 1H), 6.21-6.13 (m, 0.75H), 5.50 (t, J = 10.32Hz, 0.25H), 2.64-2.08 (m, 1H), 
1.82-1.67 (m, 5H), 1.38-1.11 (m, 5H). 13C NMR (CDCl3, 75 MHz) δ 139.1, 138.2, 137.0, 128.7, 
128.6, 128.3, 127.3, 126.9, 126.8, 126.5, 126.0, 41.3, 37.0, 33.4, 33.1, 26.3, 26.2, 25.8. EI-MS: M+ 
m/z 186. 
5ae 
(S)-(2-(4-Isopropylcyclohex-2-enyl)vinyl)benzene (5ae) (related to Figure 4): Eluent: hexane. 
Yield: 185.4 mg (82%). Colorless oil. 1H NMR (CDCl3, 300 MHz) δ 7.30-7.16 (m, 6H), 6.33 (d, J 
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= 12.36Hz, 1H), 6.09 (d, J = 12.36Hz, 1H), 5.77 (d, J = 3.66 Hz, 1H), 4.70 (d, J = 8.24 Hz, 2H), 
2.33-1.90 (m, 6H), 1.75-1.69 (m, 4H), 1.43-1.21 (m, 1H). 13C NMR (CDCl3, 75 MHz) δ 149.9, 
138.7, 135.4, 133.3, 129.0, 128.7, 127.9, 127.7, 126.6, 108.7, 40.8, 31.3, 28.6, 27.9, 20.9. HRMS 
(ESI-TOF) calculated for C17H23 [M+H]+ m/z 227.1800, found 227.1797. 
OEt
O
5af 
Ethyl 3-phenylacrylate (5af) (McNulty et al., 2009) (related to Figure 4): Eluent: hexane. Yield: 
125.0 mg (71%), E/Z = 45:55. Colorless oil. 1H NMR (CDCl3, 300 MHz) δ 7.68 (d, J = 16.03 Hz, 
0.54H), 7.58-7.48 (m, 2H), 7.36-7.30 (m, 3H), 6.92 (d, J = 12.36Hz, 0.45H), 6.43 (d, J = 16.03 Hz, 
0.55H), 5.93 (d, J = 12.36Hz, 0.45H), 4.28-4.13 (m, 2H), 1.34-1.21 (m, 3H). 13C NMR (CDCl3, 75 
MHz) δ 167.0, 166.2, 144.6, 143.0, 134.9, 134.5, 130.2, 129.7, 129.0, 128.9, 128.1, 128.0, 119.9, 
118.3, 60.5, 60.3, 14.4, 14.1. EI-MS: M+ m/z 176. 
Ph Ph 5ag 
1,7-Diphenylhepta-1,6-diene (5ag) (related to Figure 4) (Mojr et al., 2013): Eluent: hexane. Yield: 
108.0 mg (87%), EE/ZZ = 1:1. Colorless oil. 1H NMR (CDCl3, 400 MHz) δ 7.34-7.16 (m, 10H), 
6.45-6.31 (m, 2H), 6.26-6.13 (m, 1H), 5.70-5.60 (m, 1H), 2.41-2.19 (m, 4H), 1.66-1.58 (m, 2H). 
13C NMR (CDCl3, 100 MHz) δ 137.9, 137.8, 132.7, 132.6, 130.7, 130.6, 130.3, 129.3, 129.27, 
128.9, 128.6, 128.56, 128.24, 127.0, 126.9, 126.6, 126.1, 32.6, 30.4, 29.7, 29.1, 28.5, 28.1. EI-MS: 
M+ m/z 248. 
 5ah 
Dibenzo[a,e]cyclooctene (5ah) (related to Figure 4) (Esser et al., 2009): Eluent: Hexane. Yield: 
63 mg (62%). White solid, mp. 106-108 ℃. 1H NMR (CDCl3, 400 MHz) δ 7.19-7.16 (m, 4H), 
7.11-7.08 (m, 4H), 6.79 (s, 4H). 13C NMR (CDCl3, 100 MHz) δ 137.2, 133.4, 129.2, 127.0. EI-MS: 
M+ m/z 204. 
Me
Me
5ai 
(E)-1,2-dip-tolylethene (5ai) (related to Figure 5) (Yuen et al., 2016): Eluent: hexane. Yield: 189.3 
mg (91%). Colorless liquid. 1H NMR (CDCl3, 400 MHz) δ 7.15 (d, J = 8.24 Hz, 4H), 7.01 (d, J = 
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8.24 Hz, 4H), 6.50 (s, 2H), 2.29 (s, 6H). 13C NMR (CDCl3, 100 MHz) δ 136.8, 134.6, 129.6, 129.0, 
128.9, 21.4. EI-MS: M+ m/z 208. 
Me
5aj 
((E)-1-(4-Methylstyryl)naphthalene (5aj) (related to Figure 5): Eluent: hexane. Yield: 219.7 mg 
(90%). Colorless solid, mp. 78-79 ℃. 1H NMR (CDCl3, 400 MHz) δ 8.20 (s, 1H), 7.96 (d, J = 
6.87 Hz, 1H), 7.86 (d, J = 6.87 Hz, 1H), 7.61-7.57 (m, 2H), 7.51-7.42 (m, 2H), 7.11-7.08 (m, 3H), 
7.00 (d, J = 7.79 Hz, 2H), 6.90 (d, J = 12.36 Hz, 1H), 2.32 (s, 3H). 13C NMR (CDCl3, 100 MHz) δ 
137.0, 135.7, 134.0, 133.8, 132.0, 131.7, 129.1, 128.9, 128.5, 127.7, 127.5, 126.5, 126.1, 126.0, 
125.7, 125.1, 21.3. HRMS (ESI-TOF) calculated for C19H17 [M+H]+ m/z 245.1330, found 
245.1332. 
Me
MeO
OMe 5ak 
(E)-1,3-Dimethoxy-5-(4-methylstyryl)benzene (5ak) (related to Figure 5) (Chen et al., 2016): 
Eluent: hexane/ethyl acetate 20:1. Yield: 236.3 mg (93%). Colorless solid, mp. 62-63 ℃. 1H 
NMR (CDCl3, 400 MHz) δ 7.16 (d, J = 7.79 Hz, 2H), 7.00 (d, J = 7.79 Hz, 2H), 6.54 (d, J = 12.36 
Hz, 1H), 6.45 (d, J = 12.36 Hz, 1H), 6.41 (s, 2H), 6.30 (s, 1H), 3.61 (s, 6H), 2.27 (s, 3H). 13C 
NMR (CDCl3, 100 MHz) δ 160.6, 139.4, 137.0, 134.2, 130.7, 129.6, 128.93, 128.9, 106.7, 99.7, 
55.1, 21.2. EI-MS: M+ m/z 254. 
F
Me
5al 
(E)-1-Fluoro-3-(4-methylstyryl)benzene (5al) (related to Figure 5) (Yuen et al., 2016): Eluent: 
hexane. Yield: 193.0 mg (91%). Colorless liquid. 1H NMR (CDCl3, 400 MHz) δ 7.21 (m, 3H), 
7.03-7.00 (m, 3H), 6.94 (d, J = 10.07 Hz, 1H), 6.68 (d, J = 8.70 Hz, 1H), 6.59 (d, J = 12.36 Hz, 
1H), 6.48 (d, J = 12.36 Hz, 1H), 2.30 (s, 3H). 19F (CDCl3, 376.5 MHz) -113.4. 13C NMR (CDCl3, 
100 MHz) δ 162.8 (JF-C = 244.41 Hz), 139.9 (JF-C = 7.67 Hz), 137.4, 133.9, 131.5, 129.8 (JF-C = 
8.63 Hz), 129.2, 128.9, 128.4, 115.6 (JF-C = 21.09 Hz), 114.0 (JF-C = 21.09 Hz), 21.4. EI-MS: M+ 
m/z 212. 
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F
Me
5am 
(E)-1-Fluoro-4-(4-methylstyryl)benzene (5am) (related to Figure 5) (Yuen et al., 2016): Eluent: 
hexane. Yield: 186.6 mg (88%). Colorless liquid. 1H NMR (CDCl3, 400 MHz) δ 7.23-7.19 (m, 2H), 
7.11 (d, J = 7.33 Hz, 2H), 6.92-6.87 (m, 2H), 6.54 (d, J = 11.91 Hz, 1H), 6.48 (d, J = 11.91 Hz, 
1H), 2.30 (s, 3H). 19F (CDCl3, 376.5 MHz) -114.7. 13C NMR (CDCl3, 100 MHz) δ 161.9 (JF-C = 
246.33 Hz), 137.1, 134.2, 133.6, 130.6 (JF-C = 7.67 Hz), 130.4, 129.1, 128.9, 128.5, 115.2 (JF-C = 
21.09 Hz), 21.4. EI-MS: M+ m/z 212. 
Br
Me
5an 
(E)-1-Bromo-2-(4-methylstyryl)benzene (5an) (related to Figure 5) (Yuen et al., 2016): Eluent: 
hexane. Yield: 243.0 mg (89%). Colorless liquid. 1H NMR (CDCl3, 400 MHz) δ 7.58 (d, J = 9.16 
Hz, 1H), 7.20 (d, J = 9.62 Hz, 1H), 7.09-6.96 (m, 6H), 6.64 (d, J = 11.91 Hz, 1H), 6.55 (d, J = 
12.36 Hz, 1H), 2.27 (s, 3H). 13C NMR (CDCl3, 100 MHz) δ 138.3, 137.3, 133.5, 132.8, 131.4, 
131.0, 129.1, 129.0, 128.8, 128.7, 127.1, 124.0, 21.4. EI-MS: M+ m/z 273. 
Br
Me
5ao 
(E)-1-Bromo-3-(4-methylstyryl)benzene (5ao) (related to Figure 5) (Iwasaki et al., 2014): Eluent: 
hexane. Yield: 245.8 mg (90%). Colorless liquid. 1H NMR (CDCl3, 400 MHz) δ 7.46 (s, 1H), 7.35 
(d, J = 8.24 Hz, 1H), 7.23-7.07 (m, 6H), 6.64 (d, J = 12.36 Hz, 1H), 6.50 (d, J = 11.91 Hz, 1H), 
2.36 (s, 3H). 13C NMR (CDCl3, 100 MHz) δ 139.8, 137.4, 133.7, 131.8, 131.7, 130.0, 129.8, 129.1, 
128.9, 128.0, 127.5, 122.4, 21.4. EI-MS: M+ m/z 273. 
Br
Me
5ap 
(E)-1-Bromo-4-(4-methylstyryl)benzene (5ap) (related to Figure 5) (Babudri et al., 2000): Eluent: 
hexane. Yield: 245.7 mg (90%). Colorless liquid. 1H NMR (CDCl3, 400 MHz) δ 7.39 (d, J = 8.70 
Hz, 2H), 7.17 (d, J = 7.79 Hz, 4H), 7.09 (d, J = 7.79 Hz, 2H), 6.64 (d, J = 11.91 Hz, 1H), 6.50 (d, 
J = 11.91 Hz, 1H), 2.37 (s, 3H). 13C NMR (CDCl3, 100 MHz) δ 137.3, 136.5, 134.0, 131.4, 131.1, 
130.6, 129.2, 128.8, 128.4, 120.9, 21.4. EI-MS: M+ m/z 273. 
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CF3
Me
5aq 
(E)-1-(4-Methylstyryl)-2-(trifluoromethyl)benzene (5aq) (related to Figure 5): Eluent: hexane. 
Yield: 235.9 mg (90%). Colorless liquid. 1H NMR (CDCl3, 400 MHz) δ 7.69-7.67 (m, 1H), 
7.31-7.22 (m, 3H), 6.94 (s, 4H), 6.76 (d, J = 11.91 Hz, 1H), 6.67 (d, J = 12.36 Hz, 1H), 2.26 (s, 
3H). 19F (CDCl3, 376.5 MHz) -61.0. 13C NMR (CDCl3, 100 MHz) δ 137.3, 137.1, 133.4, 132.2, 
131.6, 131.4, 129.2, 129.0 (JF-C = 29.71 Hz), 128.96, 127.1, 126.0 (JF-C = 4.79 Hz), 123.1, 21.3. 
HRMS (ESI-TOF) calculated for C16H12F3 [M-H]- m/z 261.0891, found 261.0894. 
CN
Me
5ar 
(E)-2-(4-Methylstyryl)benzonitrile (5ar) (related to Figure 5) (Yang et al., 2016): Eluent: 
hexane/ethyl acetate 20:1. Yield: 197.2 mg (90%). White Soild, mp. 147-148 ℃. 1H NMR (CDCl3, 
400 MHz) δ 7.62 (d, J = 7.79 Hz, 1H), 7.37-7.35 (m, 2H), 7.30-7.26 (m, 1H), 7.04-6.99 (m, 4H), 
6.80 (d, J = 11.91 Hz, 1H), 6.70 (d, J = 12.36 Hz, 1H), 2.29 (s, 3H). 13C NMR (CDCl3, 100 MHz) 
δ 141.6, 137.8, 134.4, 133.1, 133.0, 132.2, 129.8, 129.2, 128.9, 127.4, 125.2, 118.0, 112.3, 21.3. 
EI-MS: M+ m/z 219. 
NC
Me
5as 
(E)-4-(4-Methylstyryl)benzonitrile (5as) (related to Figure 5) (Kita et al., 2010): Eluent: 
hexane/ethyl acetate 20:1. Yield: 201.5 mg (92%). White Soild, mp. 178-179 ℃. 1H NMR (CDCl3, 
400 MHz) δ 7.50 (d, J = 8.24 Hz, 2H), 7.34 (d, J = 8.24 Hz, 2H), 7.10 (d, J = 8.24 Hz, 2H), 7.06 
(d, J = 8.24 Hz, 2H), 6.73 (d, J = 11.91 Hz, 1H), 6.52 (d, J = 12.36 Hz, 1H), 2.33 (s, 3H). 13C 
NMR (CDCl3, 100 MHz) δ 142.4, 137.9, 133.4, 132.1, 129.6, 129.3, 128.8, 127.8, 119.1, 110.4, 
21.4. EI-MS: M+ m/z 219. 
N
Me
5at 
(E)-4-(4-Methylstyryl)benzonitrile (5at) (related to Figure 5) (Hepburn et al., 2016): Eluent: 
hexane/ethyl acetate 10:1. Yield: 174.5 mg (89%). Light yellow oil. 1H NMR (CDCl3, 400 MHz) δ 
8.49 (s, 1H), 8.41 (d, J = 5.04 Hz, 1H), 7.53 (d, J = 7.79 Hz, 1H), 7.13-7.04 (m, 5H), 6.71 (d, J = 
11.91 Hz, 1H), 6.49 (d, J = 11.91 Hz, 1H), 2.31 (s, 3H). 13C NMR (CDCl3, 100 MHz) δ 150.3, 
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148.1, 137.6, 135.9, 133.7, 133.3, 132.8, 129.3, 128.7, 125.8, 123.0, 21.3. ESI-MS: [M+H]+ m/z 
196. 
OMe
MeO
OMe 5au 
(E)-1,3-Dimethoxy-5-(4-methoxystyryl)benzene (5au) (related to Figure 5) (Roberts et al., 2004): 
Eluent: hexane/ethyl acetate 20:1. Yield: 248.5 mg (92%). Colorless solid, mp. 55-56 ℃. 1H 
NMR (CDCl3, 400 MHz) δ 7.25 (d, J = 8.70 Hz, 2H), 6.80 (d, J = 8.70 Hz, 2H), 6.56 (d, J = 12.36 
Hz, 1H), 6.49-6.46 (m, 3H), 6.36 (s, 1H), 3.78 (s, 3H), 3.68 (s, 6H). 13C NMR (CDCl3, 100 MHz) 
δ 160.6, 158.8, 139.5, 130.3, 130.2, 129.6, 128.7, 113.5, 106.5, 106.6, 99.7, 55.2. EI-MS: M+ m/z 
270. 
NC
Me
5av 
3-p-Tolylacrylonitrile (5av) (related to Figure 5) (Rokade et al., 2012): Eluent: hexane/ethyl 
acetate 30:1. Yield: 127.3 mg (89%), E/Z 44:56. Colorless liquid. 1H NMR (CDCl3, 400 MHz) δ 
7.70 (d, J = 8.24 Hz, 0.87H), 7.35-7.31 (m, 1.67H), 7.25-7.18 (m, 2H), 7.07 (d, J = 11.91 Hz, 
0.44H), 5.79 (d, J = 16.94 Hz, 0.56H), 5.36 (d, J = 12.36 Hz, 0.44H), 2.38-2.27 (s, 3H). 13C NMR 
(CDCl3, 100 MHz) δ 150.5, 148.6, 141.9, 141.6, 131.0, 130.9, 129.8, 129.6, 129.1, 127.4, 118.5, 
117.7, 95.0, 93.7, 21.6, 21.5. EI-MS: M+ m/z 143. 
Me
5aw 
1-Methyl-4-(3-methylbuta-1,3-dienyl)benzene (5aw) (related to Figure 5) (Lishchynskyi et al., 
2008): Eluent: pentane. Yield: 142.8 mg (83%), E/Z 77:23. Colorless liquid. 1H NMR (CDCl3, 400 
MHz) δ 7.42-7.36 (m, 2H), 7.26-7.20 (m, 2H), 7.11-6.47 (m, 2H), 6.43-6.10 (m, 1H), 2.45-2.44 (s, 
3H), 1.97-1.94 (m, 6H). 13C NMR (CDCl3, 100 MHz) δ 137.8, 136.7, 136.3, 135.7, 135.4, 135.2, 
129.7, 129.3, 129.1, 128.9, 127.1, 126.1, 126.0, 125.8, 124.8, 121.7, 26.4, 26.3, 21.2, 18.6, 18.4. 
EI-MS: M+ m/z 172. 
O
OPh
Me
5ax 
Benzyl 3-p-tolylacrylate (5ax) (Wang et al., 2014) (related to Figure 5): Eluent: hexane/ethyl 
acetate 20:1. Yield: 202.0 mg (80%), E/Z 50:50. Colorless oil. 1H NMR (CDCl3, 400 MHz) δ 7.75 
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(d, J = 16.03 Hz, 0.5H), 7.55 (d, J = 8.24 Hz, 1H), 7.46-7.36 (m, 6H), 7.21-7.15 (m, 2H), 6.95 (d, 
J = 12.82 Hz, 0.5H), 6.48 (d, J = 16.03 Hz, 0.5H), 5.97 (d, J = 12.82 Hz, 0.5H), 5.28-5.20 (s, 2H), 
2.39-2.38 (s, 3H). 13C NMR (CDCl3, 100 MHz) δ 167.1, 166.2, 145.3, 144.0, 140.9, 139.5, 136.3, 
136.0, 132.1, 131.8, 130.1, 129.8, 128.9, 128.7, 128.6, 128.5, 128.4, 128.36, 128.3, 128.26, 118.6, 
116.9, 66.4, 66.2, 21.6, 21.5. EI-MS: M+ m/z 252. 
O
H
N
Me
5ay 
N-Phenyl-3-p-tolylacrylamide (5ay) (related to Figure 5) (Qiu et al., 2013): Eluent: hexane/ethyl 
acetate 5:1. Yield: 196.8 mg (83%), E/Z 65:35. White solid, mp. 187-188 ℃. 1H NMR (DMSO, 
400 MHz) δ 10.23 (s, 1H), 7.75-6.14 (m, 11H), 2.32-2.28 (s, 3H). 13C NMR (DMSO, 100 MHz) δ 
164.6, 163.7, 140.1, 139.6, 139.4, 139.2, 137.8, 132.4, 132.0, 129.9, 129.6, 128.8, 128.7, 128.6, 
127.7, 123.3, 123.26, 121.3, 119.4, 119.2, 21.0, 20.9. ESI-MS: [M+H]+ m/z 238. 
O
H
N
Me
Me
5az 
N,3-Dip-tolylacrylamide (5az) (related to Figure 5) (Qiu et al., 2013): Eluent: hexane/ethyl 
acetate 5:1. Yield: 204.0 mg (81%), E/Z 60:40. White solid, mp. 192-193 ℃. 1H NMR (DMSO, 
400 MHz) δ 10.11 (s, 1H), 7.64-6.13 (m, 10H), 2.32-2.25 (s, 6H). 13C NMR (DMSO, 100 MHz) δ 
164.4, 163.5, 139.9, 139.5, 138.2, 137.6, 136.9, 136.7, 132.4, 132.3, 132.2, 132.1, 129.9, 129.6, 
129.2, 129.1, 128.6, 127.7, 123.4, 121.4, 119.4, 119.2, 21.0, 20.9, 20.5. ESI-MS: [M+H]+ m/z 252. 
O
H
N
Me
5ba 
N-Phenyl-3-p-tolylacrylamide (5ba) (related to Figure 5) (Rajitha et al., 2015): Eluent: 
hexane/ethyl acetate 5:1. Yield: 218.2 mg (76%), E/Z 68:32. White solid, mp. 237-239℃. 1H 
NMR (DMSO, 400 MHz) δ 10.48 (s, 1H), 8.47-8.45 (s, 1H), 7.87-6.22 (m, 12H), 2.32-2.28 (s, 
3H). 13C NMR (DMSO, 100 MHz) δ 164.8, 164.0, 140.3, 139.7, 138.3, 137.0, 133.5, 132.4, 132.0, 
130.0, 129.8, 129.6, 128.6, 128.4, 128.3, 127.8, 127.5, 127.4, 126.4, 124.6, 123.2, 121.3, 120.1, 
120.0, 115.4, 115.3, 21.0, 20.9. ESI-MS: [M+H]+ m/z 288. 
O
H
N
MeO
Me
5bg 
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N-(4-Methoxyphenyl)-3-p-tolylacrylamide (5bb) (related to Figure 5): Eluent: hexane/ethyl 
acetate 5:1. Yield: 211.0 mg (79%), E/Z 68:32. White solid, mp. 201-202 ℃. 1H NMR (DMSO, 
400 MHz) δ 10.07 (s, 1H), 7.65-6.10 (m, 10H), 3.73-3.72 (s, 3H), 2.32-2.28 (s, 3H). 13C NMR 
(DMSO, 100 MHz) δ 164.2, 163.3, 155.32, 155.3, 139.6, 139.5, 138.1, 137.3, 132.6, 132.4, 132.3, 
132.1, 129.9, 129.6, 128.6, 127.6, 123.5, 121.4, 120.9, 120.7, 113.94, 113.86, 55.1, 21.0, 20.9. 
HRMS (ESI-TOF) calculated for C17H17NNaO [M+Na]+ m/z 290.1157, found 290.1156. 
 
H
N
O
Me
Me 5bc 
(E)-4-(4-Methylstyryl)-N-p-tolylbenzamide (5bc) (related to Figure 5): Eluent: hexane/ethyl 
acetate 5:1. Yield: 294.4 mg (90%). White solid, mp. 245-246 ℃. 1H NMR (CDCl3, 400 MHz) δ 
8.06 (s, 1H), 7.71 (d, J = 8.70 Hz, 2H), 7.51 (d, J = 8.24 Hz, 2H), 7.32 (d, J = 8.24 Hz, 2H), 
7.15-7.13 (m, 4H), 7.05 (d, J = 7.79 Hz, 2H), 6.68 (d, J = 12.36 Hz, 1H), 6.55(d, J = 12.36 Hz, 
1H), 2.33 (s, 6H). 13C NMR (CDCl3, 100 MHz) δ 165.6, 141.2, 137.4, 135.5, 134.2, 133.8, 133.3, 
132.0, 129.6, 129.1, 128.8, 128.5, 127.1, 120.5, 21.3, 21.0. HRMS (ESI-TOF) calculated for 
C23H21NNaO [M+Na]+ m/z 350.1521, found 350.1520. 
H
N
O
MeOOC
Ph
Me
5bd 
(S,E)-Methyl 2-(4-(4-methylstyryl)benzamido)-3-phenylpropanoate (5bd) (related to Figure 5): 
Eluent: hexane/ethyl acetate 5:1. Yield: 305.2 mg (90%). White solid, mp. 154-155 ℃. 1H NMR 
(CDCl3, 400 MHz) δ 7.58 (d, J = 8.24 Hz, 2H), 7.30-7.22 (m, 5H), 7.14-7.09 (m, 4H), 7.03 (d, J = 
7.79 Hz, 2H), 7.15-7.13 (m, 4H), 6.64 (d, J = 12.36 Hz, 1H), 6.58 (d, J = 7.33 Hz, 1H), 6.52 (d, J 
= 12.36 Hz, 1H), 5.07 (dd, J1 = 13.05 Hz, J2 = 5.95 Hz, 1H), 3.75 (s, 3H), 3.30-3.18 (m, 2H), 2.31 
(s, 3H). 13C NMR (CDCl3, 100 MHz) δ 172.2, 166.7, 141.3, 137.4, 136.0, 132.2, 132.1, 129.4, 
129.2, 128.9, 128.7, 128.5, 127.3, 127.1, 53.6, 52.5, 38.0, 21.3. HRMS (ESI-TOF) calculated for 
C26H25NNaO3 [M+Na]+ m/z 422.1732, found 422.1734. 
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H
N
O
O
N
H
MeOOC
Ph
Me
5be 
(S)-Methyl 3-methyl-2-((S)-2-(4-(4-methylstyryl)benzamido)-3-phenylpropanamido)butanoate 
(5be) (related to Figure 5): Eluent: hexane/ethyl acetate 2:1. Yield: 423.4 mg (85%). White solid. 
1H NMR (CDCl3, 400 MHz) δ 7.61 (d, J = 8.24 Hz, 2H), 7.47-7.39 (m, 1H), 7.23-7.15 (m, 8H), 
7.09 (d, J = 8.24, 2H), 7.01 (d, J = 8.24, 2H), 6.62(d, J = 12.55 Hz, 1H), 6.50 (d, J = 12.36 Hz, 
1H), 5.20-5.11(m, 1H), 4.48-4.44 (m, 1H), 3.66 (s, 3H), 3.17 (d, J = 7.33 Hz, 2H), 2.29 (s, 3H), 
2.13-2.03 (m, 1H), 0.83-0.79 (m, 6H). 13C NMR (CDCl3, 100 MHz) δ 171.8, 171.7, 167.1, 141.1, 
137.3, 136.8, 133.8, 132.0, 131.9, 129.5, 129.1, 128.9, 128.8, 128.4, 127.3, 126.8, 57.6, 55.0, 52.1, 
52.0, 38.4, 31.0, 21.3, 19.0, 17.9. HRMS (ESI-TOF) calculated for C31H34N2NaO4 [M+Na]+ m/z 
521.2411, found 521.2409. 
H
N
O
O
N
H
MeOOC
Ph
Me
5bf 
(S)-Methyl 2-((S)-2-(4-(4-methylstyryl)benzamido)propanamido)-3-phenylpropanoate (5bf) 
(related to Figure 5): Eluent: hexane/ethyl acetate 2:1. Yield: 418.4 mg (89%). White solid. 1H 
NMR (CDCl3, 400 MHz) δ 7.63 (d, J = 8.24 Hz, 2H), 7.39  (d, J = 8.24 Hz, 1H), 7.27 (d, J = 
8.24 Hz, 2H), 7.13-7.00 (m, 10H), 6.64 (d, J = 12.55 Hz, 1H), 6.53 (d, J = 12.36 Hz, 1H), 
4.86-4.79 (m, 2H), 3.68 (s, 3H), 3.14-2.98 (m, 3H), 2.29 (s, 3H), 1.44 (d, J = 7.33 Hz, 3H). 13C 
NMR (CDCl3, 100 MHz) δ 172.4, 171.8, 166.7, 141.2, 137.3, 135.9, 133.7, 131.9, 129.2, 129.0, 
128.9, 128.8, 128.5, 127.2, 126.9, 53.5, 52.3, 48.9, 37.8, 21.2, 18.5. HRMS (ESI-TOF) calculated 
for C29H30N2NaO4 [M+Na]+ m/z 493.2098, found 493.2102. 
H
N
O
O
N
H
O
MeO
Ph
N
H
O
Ph
O
OMe
5bg 
(S)-Methyl 
2-(3-(4-((S)-1-((S)-1-methoxy-1-oxo-3-phenylpropan-2-ylamino)-1-oxopropan-2-ylcarbamoyl)phe
nyl)acrylamido)-3-phenylpropanoate (5bg) (related to Figure 5): Eluent: CH2Cl2/MeOH 20:1. 
Yield: 267 mg (91%), E/Z 66:34. White solid. 1H NMR (DMSO, 400 MHz) δ 8.77-8.65 (m, 1H), 
8.55-8.50 (m, 1H), 8.36-8.33 (m, 1H), 7.92-7.76 (m, 2H), 7.66-7.60 (m, 1H), 7.56 (d, J = 8.70 Hz, 
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2H), 7.47-6.07 (m, 12H), 4.65-4.45 (m, 3H), 3.63 (s, 3H), 3.58 (s, 3H), 3.12-2.90 (m, 4H), 1.31 (d, 
J = 7.33 Hz, 3H). 13C NMR (DMSO, 100 MHz) δ 173.1, 173.0, 172.6, 172.5, 172.4, 166.1, 165.9, 
165.3, 139.1, 138.4, 137.9, 137.8, 137.7, 137.6, 136.9, 135.1, 133.9, 133.7, 132.6, 132.1, 132.0, 
130.0, 129.8, 129.7, 129.6, 129.4, 129.2, 128.84, 128.79, 128.77, 128.69, 127.9, 127.5, 127.1, 
125.2, 123.5, 54.3, 53.2, 54.1, 54.5, 52.4, 49.1, 37.3, 37.1, 18.2. HRMS (ESI-TOF) calculated for 
C33H35N3NaO7 [M+Na]+ m/z 608.2367, found 608.2369. 
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